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ABSTRACT 
 
The presence of estrogenic hormones in the environment has been a subject of 
concern in recent years; they have been classified as “emerging pollutants” and 
may pose a potential risk for human consumption. Hormones have been detected 
in ground and surface water at low concentrations.  These compounds 
contaminate the surface and ground water via waste water treatment plants 
(WWTP) and may elicit endocrine disruption to organisms. Because these 
compounds are available at low concentration, robust analytical methods are 
required to quantify these compounds in water and environmental samples.  
 
The common method for the analysis of hormones in water samples is Gas 
Chromatography (GC) coupled to Mass Spectrometer (MS). The challenge with 
GC-MS is the required lengthy derivatisation step that involves toxic chemicals. 
 
The first part of this case study was to develop a method to determine trace 
concentrations of the Estrone (E1), 17α-Estradiol (E2α), 17 β-Estradiol (E2β) and 
17α-Ethinylestradiol (EE2) hormones using Ultra-Fast Liquid Chromatography 
Mass Spectrometry (UFLC-MS-MS). Using the developed method, the second 
part of the case study was to determine the concentrations of the hormones in raw 
and potable water samples from the Vaal River catchment area in the South of 
Johannesburg, South Africa.   
 
Analytes were extracted by solid phase extraction (SPE C18 Sorbent, 200 mg/6mℓ 
cartridges) and subjected to Ultra-Fast Liquid Chromatography coupled to Mass 
Spectrometer (UFLC-MS-MS) for identification and quantification. Optimum 
SPE parameters were 1000 mℓ of sample percolated, at flow rate of 10 mℓ/min, 
sample pH of above 7, 7.5 mℓ of methanol as elution solvent followed by solvent 
reduction to 250 µℓ. 
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The limits of quantification were in a range of 0.24 to 0.32 ng/ℓ for all analytes. 
Accuracy was 95.6, 93.8, 97.6 and 100.9% for 17α-Ethinylestradiol, 17α-
Estradiol, 17β-Estradiol and estrone, respectively. In raw water samples taken 
during the rainy wet season, estrone was detected at concentrations of 0.90 and 
4.43 ng/ℓ. However, drinking water samples no presence of hormones with the 
exception of M-B12 sample point where the estrone amount of 2.88 ng/ℓ was 
detected. This is potentially due to fact that conventional water treatment plants 
are able to remove the compounds during water purification process depending on 
the concentration levels. 
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CHAPTER ONE – INTRODUCTION 
 
1.1 General Introduction 
 
The concerns posed by endocrine disrupting chemicals (EDCs) has 
been a public health subject for some time now, EDCs are compounds 
that are available in the environment they interfere with hormonal 
function, synthesis and metabolism, or mechanisms resulting in the 
alteration of homeostatic function or reproduction (Maria Huert-
Fontel et al,. 2010, Jones-Lepp et al.. 2009, Ncube,.2009, Diamanti-
Kandarakis et al,. 2009). Hormones are class of chemical compounds 
secreted by glands in certain parts of the body that sends out signals 
that affect cells in other parts of the body. Only a small amount of 
hormone is required to alter cell metabolism. In summary, a hormone 
is a chemical compound that transports a message from one cell to 
another. 
According to the studies performed in the first Scientific Statement of 
The Endocrine Society (Diamanti-Kandarakis E et al. 2009), the 
effects such as prostate cancer, cancer, breast development, and 
thyroid, and neuroendocrinology, male and female reproduction just to 
mention a few are the effects of endocrine disrupters.  
The mechanisms of endocrine disrupters in the body system involves 
more than one pathways such as estrogenic, thyroid,  anti-androgenic, 
peroxisome proliferator-activated receptor, retinoid, and interaction of 
receptors the nuclear; steroidogenic enzymes; neurotransmitter 
receptors and systems. Their pathways in human and wildlife can be 
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investigated in the laboratory using in vitro and in vivo models 
(Diamanti-Kandarakis et al,. 2013). The significance of ECDs 
resulting from epidemiological and toxicological studies to animal and 
human are currently converged as a public health concern. 
The occurrence of these contaminants in water streams possesses 
environmental concerns and is an issue for public health matters. 
Endocrine disrupting compounds (EDCs) such as steroid hormones 
and pharmaceuticals have been classified as “Emerging contaminants” 
because of their endocrine disrupting potential. Little is known about 
their availability, fate and toxicity of these compounds in source and 
drinking water in South Africa. 
Additionally, compounds such as organo-chlorine pesticides, 
plasticisers, fuels, industrial chemicals, brominated flame retardants 
and other chemicals that might be present in the environment are in 
use in large quantities in South Africa. Pesticides are the only organic 
pollutants most studied in the South African environment (Yang et al,. 
2010), followed by PCBs and now PAHs (Combalbert et al,. 2012, 
Sibiya,.2011). 
Studies have shown that these compounds result from direct disposal, 
human and animal excretion and enter water streams via Waste Water 
Treatment Plants (WWTP), due to inability of WWTPs to remove 
some of these compounds together with their metabolites in the 
effluent. EDCs may be found in surface water and in sediments at 
very low concentrations depending on the location of WWTPs. If the 
remaining sludge is used for agricultural purpose, EDCs have a 
potential of leaching through soil hence contaminating the 
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environment. Therefore, the presence of such EDCs poses a threat to 
the environment and on the water quality together with unknown 
toxicological effects (Huert-Fontel et al. 2010). 
The public health effect caused by emerging organic contaminants has 
attracted regional and international concerns when released into the 
environment.  Organic pollutants that are disposed into the 
environment include agricultural waste, industrial pollution and other 
hazardous pharmaceuticals and personal care products that are not 
biodegradable. It has been widely reported that most organic emerging 
contaminants such as dyes, detergents, paint substance, agricultural 
waste, additives to plastics, paint components and PPCPs also possess 
endocrine disrupting effects (Huert-Fontel et al. 2010, Theres Koal et 
al. 2011, Mu¨llera et al. 2002, Ncube, (2009) and Diamanti-
Kandarakis E et al. 2009). 
 
Ncube (2009) revealed that the human risk of long-term exposure to 
the low levels of most organic contaminants, especially emerging 
contaminants such as hormones are not yet known throughout the 
world. Thus, there is a need to monitor these emerging contaminant in 
South African water resources.   
 
Little is known of the availability or absence of hormones and PPCPs 
in raw waters that is treated for drinking water.  The need for further 
studies on detection of these emerging pollutants should be of utmost 
importance to ensure the health and safety of consumers. Several 
research articles have been written that discuss the fate and behaviour 
of these emerging pollutants in waste water effluents (Huerta-Fontela 
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et al., 2011),  but few articles have been written on their detection and 
fate in drinking water in South Africa (Huerta-Fontela et al., 2011). 
The lack of systematic monitoring programmes in South Africa and 
fluctuating concentrations of hormones with inadequate analytical 
method limits of detection may possibly exacerbate the situation.  
 
In other studies, the availability and effects of hormones, 
pharmaceuticals and their transformation by-products in drinking 
waters have been reviewed (Jones et al,. 2005, Mompelat et al,. 2009). 
Until recently, some studies have found the availability of these 
contaminants in European and United State of American (USA) 
drinking waters at low concentrations (Huerta-Fontela et al., 2011). 
However, there is a challenge in formulating appropriate standards for 
organic substances in water due to the complexity of this group of 
chemicals, their ability to degrade into other organic substances, the 
difficulty in analysing these substances at the required ultra-low 
concentration levels, the high cost of analyses and the extensive 
resources and skills required to perform such analyses. There is also 
insufficient knowledge on the probable health implications of many of 
these substances hence the reason for taking a cautious approach 
resulting in the near impossible detection limits required for many of 
these organic constituents.   
The presence  of endocrine disrupting compounds (EDCs), 
pharmaceutical and personal care products in waste and surface waters 
has attracted lots of attention and focus in the recent years 
(Richardson et al., 2009). If these compounds together with their 
metabolites are not removed from waste water treatment plants, they 
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may enter rivers and streams which can have adverse impact in the 
aquatic life and the quality of potable water for consumption. (Maria 
Huerta-Fontela et al., 2011). 
 
Low concentrations result in effects such as feminization. Because 
these compounds are available at low concentration, robust analytical 
methods are required to quantify these compounds in water and 
environmental samples. (Huerta-Fontela et al., 2011; Izumi et al., 
2009). The common method for the analysis of hormones in water 
samples is gas chromatography (GC) coupled to a mass spectrometer 
(MS). The challenge with GC-MS is the required lengthy 
derivatisation step that involves toxic chemicals (Huerta-Fontela et al., 
2010; Huert-Fontel et al., 2011).  To take advantage of the weaknesses 
of immunoassays methods in the determination of hormones, high 
performance liquid chromatography coupled to tandem mass 
spectrometry is a good alternative. HPLC-MS-MS is capable of 
simultaneous determination various organic pollutants in 
environmental samples while producing good accuracy, sensitivity 
and precision. HPLC –MS-MS has also been applied in toxicological 
diagnostics and therapeutic drug monitoring in the past decade (Koal 
et al., 2012).  
Like all hyphenated techniques, UFLC-MS-MS requires several 
technical modifications before it can be applied to routine analysis. 
Proper instrument optimisation is necessary to increase efficiency, 
accuracy, precision and to decrease bias and uncertainty (Müller et al., 
2003; Izumi et al., 2009; Huerta-Fontela et al., 2011).  
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Although immunoassays have been used in diagnostics of pollutants 
because they are fast and thus have high sample throughput, they have 
some drawbacks.  The disadvantages of bioassays in the analysis of 
hormones are as follows (Sabine Mu¨llera et al. 2002):  
 It is not suitable for multi-compound determination but often 
the sample contains a number of similar compounds. 
 Low ability of selectivity and specificity because some 
metabolites have similar structural orientations. 
  Less sensitive especially in testosterone analysis  
 Linear dynamic range is limited because of interferences 
associated with complex matrices  
 The kits that are used in immunoassay methods vary 
significantly and their standardisation are not always traceable. 
  
In this study, method for the simultaneous identification and 
quantification of hormones in water matrices has been developed and 
validated using a highly advanced UFLC coupled to MS-MS. This 
method was applied to the determination of hormones in raw and 
treated potable water samples in the south region of Johannesburg, 
South Africa. 
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1.2 Statement of a problem 
 
Despite the low concentrations of EDCs, the fate of hormones in the environment 
together, with their persistent biological activities explains the concern over this 
specific group of water contaminants. First reports dealing with the availability of 
EDCs/ pharmaceutical and personal care products in environmental water samples 
were performed by using gas chromatography (GC) following derivatisation.  
Various studies conducted in water analysis still shows apparent existence of 
PPCPs in the environment water samples (Chung Chow Chan et al. 2004). 
Because of the ecotoxic effect of both natural and synthetic hormones such as E1, 
E2s and EE2 are of concern even at low concentration levels. A concentration of 
approximately 1 ng/ℓ is enough to cause feminisation which reflects the extent of 
endocrine disruption potential of these contaminants (Ali Khan, et al, 2011). The 
status of these compounds in South African water bodies is not known because 
very little studies have been reported.   
As a result of very low concentrations expected in the water bodies, a more robust 
analytical methodology is required for the accurate identification and 
quantification of these compounds in environmental samples. Estrogen residues in 
water and sediments have commonly been determined using GC/MS; the main 
challenge with this technique is that it requires samples to be derivatised which 
involve time consuming and tedious steps rendering it unsuitable where the 
turnaround time and sample throughput is expected to be high. 
This study investigates the power of LC/MS/MS for the analysis of four hormones 
using Solid Phase Extraction (SPE) approach of potable water and raw water 
source samples. Liquid chromatography coupled to mass spectrometry (MS; 
MS/MS) is the preferred technique for multi-analyte determinations of polar 
compounds such as hormones. 
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CHAPTER TWO – LITERATURE 
 
2.1  Occurrence of hormones 
 
 
Recent research work has been directed towards the occurrence of estrogenic 
hormones in the environment (Komori et al,.2004). In general, steroid hormones 
are biological compounds that are synthesised from cholesterol. Natural hormones 
various human and animal organs including ovaries and adrenalin to mention but 
a few (Guang-Guo Ying et al., 2002) 
 
The group of compounds in this study is primarily produced in the female body 
and is essential for female characteristics such as keeping reproductive cells 
healthy. These types of hormones can also be synthesised commercially. 
Hormones such as estrone and 17β-estradiol are naturally excreted by females 
(both human and animals) in the quantities of 2–12 μg/person/day and 3–20 
μg/person/day, respectively (Belfroid A.C et al., 1999; Guang-Guo Ying et al., 
2002). Several drugs are used in medicine to influence the endocrine hormonal 
system. One well known example is the contraceptives utilized as ingredients of 
birth control pills. A synthetic steroid hormone of concern that is studied here is 
ethinylestradiol which is used as a contraceptive.     
 
Like all endocrine disruptors, hormones exert their action by passing through the 
plasma membrane and binding to intracellular receptors. They may interfere with 
the normal functioning of endocrine system resulting in the negative impact in the 
reproduction and development in aquatic life. 
 
Many effects observed in the aquatic environment concerning the reproductive 
system, like the feminisation of male fish within WWTP effluents are attributed to 
the presence of endocrine disrupters but the specific individual compounds or 
group of compounds attributed to this effect are still not known as a matter of fact 
11 
 
(Ternes et al., 1999). Other suspected endocrine disrupting compounds such as 
nonylphenols, phthalic esters, polychlorinated biphenyls, dioxins, phytoestrogens 
and human estrogens are suspected to influence the hormonal system.  Recent 
studies have hypothesised that the statistically derived decrease in sperm counts 
over the last decades, increasing incidents of testicular cancer and other disorders 
regarding male infertility may be caused by the intake of estrogens via food or 
drinking water (Diamanti-Kandarakis et al, .2009).  
 
Some of the main synthetic sources of larger part of environmental pollutants are 
pharmaceutical production, wastewater treatment plants, agricultural activities and 
fish farming (Boxall et al, .2012). Conventional drinking water treatment 
processes such as coagulation/flocculation, sedimentation and chlorination are not 
primarily designed to remove completely these organic pollutants unless assisted 
by granular activated carbon filtration or membrane filtration (Wang  et al., 2012; 
Kim et al., 2007). Kim et al., (2007) further reported that in wastewater treatment 
processes, membrane bioreactors (MBR) achieves limited target compound 
removal, but are effective at eliminating hormones and some pharmaceuticals. 
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2.2 Occurrence of Pharmaceuticals and Personal Care Products 
(PPCP) 
 
 
In general, Pharmaceuticals and Personal Care Products (PPCP) and other organic 
compounds which are used around the globe in big quantities are found in 
Municipal wastewaters (Ramirez et al,. 2009, Kasprzyk-Hordern et al 2008, 
Chenxi et al,. 2014).  
Drugs that are used for human consumption are subjected to metabolic processes; 
significant portion of these drugs leaves human or animal bodies un-metabolised 
via excretion and therefore emitted into raw sewage (Carballa et al,. 2004). 
Furthermore, some of the excreted metabolites can be transformed back into their 
original form (Carballa et al,. 2004). 
 
Some of PPCPs such as fragrances, galaxolide naproxen which is an anti-
inflammatory, ibuprofen, 17 β-estradiol, iopromide, sulfamethoxazole which is an 
antibiotic, estrone and, diclofenac, roxi-thromycin, 17 α-ethinylestradiol, 
diazepam, and carbamazepine have been detected in the work carried out by 
Carballa et al  (2004) in the wastewaters in north west Spain.   
 
The availability of pharmaceuticals and personal care products in sewage water 
can be used as an indicator of organic pollution of municipal waste waters 
generated by possibly hospitals, cities, informal settlements and agricultural 
activities around the population of the study area such as Vaal region 
(Johannesburg, south) in Gauteng, a province in South Africa. 
Most work reported in the literature deals with the availability of these organic 
pollutants in waste water treatment plants followed by their removal, little or no 
information is available for assessment of the fate of these compounds in the 
environment especially in the receiving and drinking water bodies. The study is 
thus very important for South Africa as very few studies have been reported of 
these compounds in the environment. 
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2.3 Environmental and Public Health Impact of EDCs 
 
 
Estrogens are known as hormones that regulate reproductive functions in females, 
they also play a role in bone protective tissues, brain and the cardiovascular 
system.  
 
The major hormone of concern when it comes to binding capacity to the estrogen 
receptor is estradiol. It can further be metabolised to form estrone and 
consequently estriol through further oxidation processes (Reina et al,. 2004). 
Estradiol is used as precursor towards the synthesis of man-made estrogens such 
as ethinylestradiol (EE2), mestranol and the valerate of estradiol which are used in 
human hormone therapy treatments, like the contraceptive pill as stated above. 
Before they are excreted by the body system they are first metabolised to inactive 
biological state and soluble(water) conjugates of glucuronides or sulphate esters, 
however a bacteria can deconjugate them and make them biodegradable in 
activated sludge process with the synthetic estrogens of greater recalcitrance 
(Bevan et al,. 2012). 
 
The hormones are synthesized in both males and females along with estrogen 
receptors (ERs).  ERs act as ligand-activated transcription factors (Reina et al 
2004). These hormones interact with intracellular ERs and activate the expression 
of gene encoding proteins, which in turn control the important biological 
functions in animals and humans (Klinge et al,.2008). Those receptors have higher 
affinity for 17β-E2 than the other estrogens; thus, 17β-E2 binds more vividly to 
the receptors and it is recognized as the predominant endogenous activator and 
initiator for a number of downstream ER-mediated cellular events (Maria Marino 
et al,. 2006). In contrast, 17α-E2 is generally considered to be a less active and 
feminising estrogen (Nguyen (2010) Thesis) 
 
Estrogens are eliminated from the body by conjugation to hormonally inactive 
water-soluble metabolites, mainly the sulphates and glucuronides. Estrone 
sulphate is the most abundant circulating estrogen at a concentration of 10 times 
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higher than that of unconjugated estrone (Nguyen, .2010). This finding affirms the 
belief that sulphated steroid hormones serve an important role as steroid hormone 
precursors, and sulphation/desulphation processes of estrogens may represent a 
vital endogenous system in regulation of biologically-active steroid hormones in 
target tissues (Nguyen,.2010). A current hypothesis is noted, that inactive estrone 
sulphate is transported to target tissues via the circulatory system and taken into 
target cells, most likely by anion transporters (Notelovitz et al 2007). After arrival 
in target cells, estrone sulphate is enzymatically hydrolysed to E1 by intracellular 
membrane-bound sulphatases, and then, catalytically oxidized to active 17β-E2 by 
17β-hydroxysteroid dehydrogenases (Nguyen, .2010). The transport of estrogen 
conjugates into target cells is not well understood, but it is believed that the 
process occurs by virtue of the high affinity of anion transporters for both 
estrogen sulphates and glucuronides. Estrogen glucuronides have received less 
attention as steroid hormone precursors, primarily because of their less abundance 
and more ready excretion from the body (Notelovitz et al 2007). 
 
17α-ethynylestradiol (EE2) for an example is a known synthetic hormone, derived 
from the natural hormone, estradiol (E2). It has been used widely as medication in 
livestock as well as in humans however it creates challenges in the environment 
due to its high resistance to degradation, absorbs organic matter, accumulates in 
sediment, and concentrates in biota (Jones-Lepp et al,. 2009 : Yinga et al,. 2002: 
Belfroid et al,. 1998 , Guang-Guo et al,. 2008  : Horbart,. et al ,1988). EE2 is used 
widely as a contraceptive in females and studies have reported the ability of EE2 
to alter sex determination, delay sexual maturity, and decrease the secondary 
sexual characteristics of exposed organisms even at a low concentration (ng/l) by 
mimicking its natural analogue, 17β-estradiol (E2) (Aris et al,. 2014). 
 
Moreover, it has been demonstrated that estrogens that are used in hormone 
therapy can prevent and decrease the incidence of stroke-related mortality in 
postmenopausal women (Yinga et al,. 2002). It has also been demonstrated that in 
pre- and post-ischemic 17β-estradiol (17β-E2) and its less bio-active metabolite, 
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estrone (E1), have been the endogenous estrogens of greatest interest (Horbart,. et 
al ,1988,  Ncube,. 2009, Nguyen ,.2010, Belfroid et al,. 1999). 
 
The study conducted by Drake et al. (2000) found a positive association between 
circulating estradiol and delayed verbal memory, but a negative association 
between circulating estradiol and immediate and delayed visual memory in 
healthy postmenopausal women not on estrone replacement therapy (ERT). 
 
Another study conducted by Yaffe et al., (2000) found that women with high total 
E2 and bioavailable E2 were less likely to demonstrate cognitive decline over a 6-
year follow up period, even after adjusting for current ERT use. Other studies 
have found that verbal skills are enhanced during the estrogen-dominant phase of 
the menstrual cycle (Benotti et al,. 2009, Nguyen,.2010).  
 
The release of estrogens into the environment possesses endocrine disruptive 
potential even at low concentration levels (Maria Huert-Fontel et al,. 2010, 
Yoshihiro Izumi, et al,. 2009). This is related to various other conditions linked to 
reproductive abnormalities, decreased fertility and feminization and related to 
various types of cancer, prominently ovarian and breast cancer (Aris et al,. 2014). 
Figure 2 shows the mechanism of cancer formation from estrogens. 
 
Figure 2:  Metabolic redox cycling of 4-hydroxyestradiol (Nguyen,.2010) 
 
In Figure 2, in the first stage target tissues or cells are subjected to excessive 
mitogenic (a chemical process that encourage a cell to divide) stimulation by 
estrogens which increases cell production. In the second stage, 4-hydroxyestradiol 
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undergoes metabolic redox cycling to produce free radicals of 
semiquinone/quinone. These metabolic intermediates may damage DNA, proteins, 
lipids, induce cell transformation, and cause tumorigenesis. 
                                                                                    
2.4 Chemical, Physical and Structural properties of the    
Compounds of interest in this study 
 
Natural estrogens, consisting of estrone (E1), estriol (E3), 17α- and 17β-estradiol 
(17α- and 17β-E2), are steroid hormones with the general skeleton as shown in 
Figure 3, generated from cholesterol via testosterone and androstenedione in 
ovaries, brain, and body fat deposits.  
 
Figure 3:  Structure of estrogen hormones (Huerta-Fontela et al,.2011) 
 
EE2 (19-nor-17α-pregna-1, 3, 5(10)-trien-20-yne-3, 17-diol) is a derivative from 
the natural hormone, estradiol (E2) (Aris et al,.2014). EE2 is used in almost all 
modern formulations of combined oral contraceptive pills and is one of the most 
commonly used medications. It is worth noting that EE2 is sparingly soluble in 
ethanol (1 part in 6 parts of ethanol), but has relatively low solubility in water (4.8 
mg/l at 20 °C) compared to natural estrogenic steroid (Table 1). 
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Table 1:  Physical and chemical properties of estrogens (Lai et al, 2000, 
Carpinteiro et al, 2004 and Lewis and Archer, 1979) 
 
Estrogen Molecular 
weight 
Vapour 
pressure 
(Pa) 
Water 
solubility 
(mg/l) 
Log Kow 
(ESC) 
Log Kow 
Estradiol 272.39 3E-08 13 3.94 4.01/3.10 
Estrone 270.37 3E-08 13 3.43 3.13 
Estriol 288.39 9E-13 13 2.81 2.60 
EE2 296.40 6E-09 4.8 4.15 3.67 
Mestranol 310.42 1E-07 0.3 4.67 4.10 
 
Estrogen metabolism is presented in Figure 4. Estradiol and estrone are 
synthesized from the precursor of cholesterol through the formation of 
testosterone and androstenedione. Once formed, these three estrogens can be 
interconverted between each other or hydroxylated to estriol (Aris et al,. 2014). 
All native estrogens can also be conjugated by sulphation or glucuronidation and 
vice versa (Nguyen,. 2010) 
 
 
 
Figure 4:  Estrogen metabolism (Nguyen,. 2010) 
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2.5 Review of Common Extraction Techniques 
 
 
Sample preparation and handling, “a heart of measurement analysis”, plays a very 
important role in the measurement of the analytical data. Wrong sampling and 
sample preparation procedures will lead to invalid and misleading interpretation 
of results. 
 
Most samples are not ready for direct introduction into instruments; mostly 
analytes must be in a suitable phase or state to be amenable for specific 
instrumentation. For example, in the analysis of estrogens in water sample, it is 
not possible to analyse the water directly into the GC-MS. The analytes have to be 
extracted into a solution and derivatised, before they can be analysed by an 
instrument. 
There might be several processes within sample preparation itself depending on 
the nature of the sample. Sample extraction choice can be helped by classification 
of the analyte whether it is volatile or semi volatile. 
 
Liquid-liquid extraction 
 
Liquid-liquid extraction is a solvent based extraction technique whereby non-
polar organic solvents which are immiscible in an aqueous media are used to 
dissolve analyte of interest from water matrix based on the differences between 
the solubility of analytes in the organic and aqueous phases. Target compound can 
be extracted selectively by using a solvent whose polarity is similar to that of the 
analyte of interest. However, in practice, other matrices with similar polarity as 
the analyte are extracted along making the method less attractive. 
 
Semi-volatile organic compounds in water samples are normally extracted using 
organic solvents such as dichloromethane, hexane, ether, benzene and ethyl 
acetate. When non-polar compounds such as aliphatic hydrocarbons are to be 
extracted, hexane is normally a suitable solvent for their extraction. Benzene is 
normally preferred for the analysis of aromatic compounds whereas ether and 
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ethyl acetate are normally used for the extraction of polar compounds containing 
oxygen. Dichloromethane has high extraction efficiency for a wide range of non-
polar to polar compounds. 
 
Dichloromethane is suitable for simultaneous analysis because of the following 
advantages: it has a low boiling point and easy to re-concentrate after extraction, it 
has a higher specific gravity which makes it easy to separate from water, and it is 
non-flammable.  
 
However, these organic solvents (hexane, benzene and others) are known 
carcinogens, and recently the call towards minimising the use of these solvents 
during sample preparation has been encouraged. It is sometimes possible to 
selectively extract semi-volatile compounds from water by changing the character 
of samples, not changing solvents. For example, by changing the pH of samples, 
only acidic or basic substances can be extracted. When the pH of water is less 
than 2, basic compounds become fully ionised and are not extracted by the 
solvent, allowing selective extraction of acidic and neutral compounds (Ram 
Chandra,. 2015). 
 
In the extraction water soluble compounds, salting-out techniques are used to 
enhance or aid the rate of extraction. Addition of a salting agent in to the aliquot 
of a water sample reduces the solvation power of the solution and the solubility of 
target compounds. This is also useful in solid phase extraction and headspace 
extraction techniques.  
 
Extraction is normally performed in a separating funnel by vigorously mixing the 
aqueous phase sample with a suitable organic solvent. Sometimes the formation of 
emulsion prevents the proper extraction to occur. If ever the formation of 
emulsion occurs, addition of anhydrous sodium sulphate, ethanol followed by 
sonication can break down the emulsion making the extraction more effective and 
efficient (Skoog et al, 1998). Because of the lengthy extraction time by continuous 
liquid- liquid extraction techniques, thermally unstable compounds cannot be 
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extracted with high level of efficiency even though the technique itself is regarded 
efficient (Tölgyessy et al, .2004, Skoog et al, 1998). 
 
Solid-Phase Extraction (SPE) 
 
SPE is modern and robust; it is an alternative extraction technique for liquid-
liquid extraction (LLE). 
Solid phase extraction principle is based on adsorption and desorption. Analytes 
of interest are adsorbed into a suitable sorbent in a cartridge (usually C18).  
 
The SPE can remove matrix interferences in complex samples by passing through 
the suitable cartridge or by elution with the solvent and then desorbing the target 
compounds with a suitable solvent selective to the group of target compounds. 
SPE uses less amounts of organic solvent when compared to liquid-liquid 
extraction and can be automated easily. Common solid phases used as packing 
materials are reversed phase and polymeric sorbents. The recovery analysis can be 
determined where known quantities of standard are added into the known sample 
matrix volume, subjecting the samples through solid phase extraction column, 
eluting the target analytes using the suitable solvent and subsequently determining 
the amount of analyte recovered in order to get better results. 
 
There are commercially available cartridges which are pre-packed with known 
amounts of adsorbents; they can simply be conditioned before use in the 
laboratory. Just like any one technique, SPE has advantages and disadvantages as 
given below: 
 
The advantages of SPE technique: 
 Can easily be automated 
 Use small volume of organic solvent. 
 Simultaneous extraction is easily performed thus giving high sample 
throughput. 
 Large number of sorbents to choose from some which are selective. 
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 High concentration factors can be obtained. 
 
The disadvantages to solid-phase extraction technique: 
 
 The solvent flow rate can affect the recovery rate of analytes. 
 
 Suspended solid composition must be separated from the water sample. 
 
 It is possible to get analyte breakthrough in highly contaminated matrices 
 
 It is important to optimise the method by testing various factors that affect 
recovery and reproducibility in order to improve method capability  
 
 
Henriques et al,. (2010) reported that estriol, 17--ethinylestradiol, 
diethylstilbestrol, Mestranol, estrone and 17-β-estradiol were not detected in all 
tested Lisbon drinking waters using solid phase extraction. Some raw waters (43 
samples) in Portugal showed trace amounts of other endocrine disrupting 
compounds such as bisphenol A, progesterone, 4-tert-octylphenol, and 4-n-
nonylphenol. The quantities of endocrine disruptive compounds in the samples 
where were in the region of 2.9 - 4.8 ng/ℓ for bisphenol A, 27 - 29 ng/ℓ for 4-tert-
octylphenol, 0.45 - 1.8 ng/ℓ for progesterone and 2.7 - 5.7 for 4-n-nonylphenol 
(Henriques et al,. 2010). 
 
Hollow fibre liquid phase micro-extraction (HF-LPME) 
 
In HF-LPME the extracting phase is placed inside the lumen of a porous 
polypropylene hollow fiber in which the extraction solvent is protected and 
stabilized (Sibiya, .2012).  
 
The most common fiber has a porosity of 70%; a pore size of 0.2 μm, a wall 
thickness of 200 μm and an internal diameter of 600 μm. A supported liquid 
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membrane (SLM) is formed easily by dipping the hollow fiber into the organic 
solvent for a few seconds. The solvent penetrated the pores of the hollow fiber 
and is bound by capillary forces to the polypropylene network comprising the 
fiber wall.  The inside of the fibre with filled organic solvent acts as the trapping 
media.  
 
In HF-LPME, analytes are extracted from an aqueous sample, into the organic 
solvent immobilized as a SLM, and into the acceptor solution placed inside the 
lumen of the hollow fiber.  
This acceptor solution may be an organic solvent (same as used for the SLM) 
resulting in a two phase extraction system, or the acceptor solution may be 
aqueous that is immiscible with SLM solvent providing a three-phase extraction 
system (Sarafraz-Yazdi et al,. 2010).  
 
Subsequently, the acceptor solution is removed by a micro-syringe and transferred 
to final chemical analysis. Two-phase HF-LPME could be done in two ways: 
direct immersion extraction (DI) and headspace extraction (HS) (Sibiya, .2012, 
Sarafraz-Yazdi et al,. 2010). The mechanisms such as pH gradient, carrier 
transport and electro membrane extraction can be used to facilitate the three 
phased mode of HF-LPME (Ghambarian et al, 2012). 
 
Hollow fibre-protected liquid-phase micro-extraction (HF-LPME) was used by 
different researchers. Padrón et al,. (2014) discovered that after optimising the 
LPME method, very clean extracts could be obtained, avoiding signal suppression 
during the LC-MS/MS analysis of the analytes; the limits of quantification in their 
developed method ranged from 0.5 to 42 ng/ℓ. For estrogens (estrone, 17β-
estradiol, estriol, ethynylestradiol, diethylstilbestrol), the limit of detection ranged 
from 2.7–11.7 ng/ℓ when IT-SPME was used in Spain (Padrón et al,. 2014). 
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Selective sorbents based on Molecular Imprinted Polymers (MIPs) 
 
Molecular Imprinting Technology (MIT) is a novel synthetic approach to develop 
robust molecular recognition materials that are able to mimic natural recognition 
of compounds such as antibodies. The synthesised polymers, which are able to 
mimic and achieve recognition, found in nature, have become an emerging and 
active area of research today.  They are also known as plastic antibodies and 
operate on the basis of lock and key principle. 
 
MIPs provide specific molecular recognition ability for selective retention 
(Bartsch et al., 1999). In the traditional way of preparing MIPs, the target 
molecule is used as a template. After polymerization, the template is removed, 
and the specific recognition site created selectively adsorbs the template molecule 
which is the target compound in the sample.  
 
MIPs have been applied in different fields of analytical separations including LC 
columns as stationary phases (Sellergren at al., 2000). It is very difficult to 
completely remove the template molecules from the prepared MIPs, even by 
washing with some organic solvents repeatedly. In microanalysis, leakage of the 
residual template molecules, which are the same as the target molecules, prevents 
the accurate determination of the target compound. This can be a serious problem 
for quantitative microanalyses of chemical substances such as E2 at the ng/ℓ level 
(Kubo et al., 2012). As a result, a structurally-related analog, which can be 
separated from the target molecule in the subsequent chromatographic process, is 
employed as the template molecule instead (Watabe et al,. 2006). 
 
In the study conducted in China, the recoveries from the MIP–SPE method were 
in the range of 87.5–97.3% when analysing for diethylstilbestrol (DES) in fish 
samples. The detection limit (LOD) was obtained from the signal-to-noise ratio 
(S/N) and calibration curve. In this work, the noise of the baseline was measured 
from chromatogram of blank fish sample. Three times of the noise as the signal 
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value (S/N = 3) was used to calculate the LOD in the calibration curve. The LOD 
obtained was 60 ng/mℓ (Jiang et al,.2008). 
 
In the separate study done in Czech Republic, the LOD of estrogens, bisphenol A, 
and alkylphenols in their water and sediments samples ranged in between the 
region of 0.70 – 1.90 ng/ℓ and 0.30 – 0.60 ng/g respectively. The use of MIPs in 
their extraction contributed greatly in the sample clean-up stage, its efficiency was 
increased even when larger samples quantities were used. (Matějíček et al,.2013). 
 
The concentration levels of 18.5 to 34.5 ng/ℓ for bisphenol A and 7.2 to 8.4 ng/ℓ 
for nonylphenol were found in four samples. There were three samples where 
estrone was detected and quantified, it was found in the concentration region of 
3.4 – 5.1 ng/ℓ.  
Ten samples were collected from Svratka for analysis. Bisphenol A and 
nonylphenol were detected in all ten samples in the region of 14.6 to 83.2 ng/ℓ for 
bisphenol A and 6.7 to 9.4 ng/ℓ for nonylphenol. Estrone was detected in 70% of 
samples collected in the region of 7.2 – 9.2 ng/ℓ concentration levels. Estradiol 
was detected only in three water samples. Of the sediments samples collected in 
the Svratka River, only estrone and nonylphenol were detected (Matějíček et 
al,.2013).The use of MIP can therefore be a good alternative to SPE due to its 
adequate limits of detection at low ng/ℓ concentration levels.  
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2.6 Review of Common Analytical Methods of Analysis 
 
This section describes a few techniques that are available for the determination of 
estrogenic hormones in the water and environmental samples.  
 
2.6.1 Immunoassays 
 
Estrogens are have been widely analysed by biological assays (Rubing et 
al,.2011). Use of bioassays makes sense since endocrine disruptors or endocrine 
disrupting chemicals are exogenous substances or mixture that alters function(s) 
of the endocrine system (hormonal system) by binding to hormone receptors and 
then causes endocrine disruptive effects in an organism or its offspring.  
 
The basic principle of bioassay is based on the comparison between the sample 
with the international standard of the same type in order to determine the how 
much substance is required to produce similar biological effect, as produced by 
the standard. They represent the fixed units of activity (definite weight of 
preparation) for drugs (Ramesh,. 2008). 
 
An agonist may produce graded response or quantal response. Graded response 
means that the response is proportional to the dose and response may lie between 
no response and the maximum response. Quantal response is form of "all or 
none", i.e. either no response or maximum response. The drugs producing quantal 
effect can be bioassayed by end point method. The drugs producing graded 
responses can be bioassayed by matching or bracketing method or graphical 
method (Ramesh, 2008). 
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The identification and quantification of bioassays 
 
Types of bioassays  
 
(i) On a basis of intent: On the basis of intent, bioassays can be classified in 
one of two main groups, - absolute or comparative. Absolute assays: 
Absolute assays involve an attempt to obtain some quantitative 
measurement that can be expressed in absolute terms, such as a Minimal 
Lethal Dose (MLD) or Median Effective Dose (ED 50, LD50, etc.). Such 
attempts are based on the assumption or belief that some such absolute 
value exists and that universally it can be determined with adequate 
precision. However, the absolute potency of substance X for 'the cat" 
typically depends on just which cat is used and, unfortunately, cats 
invariably do differ. Laudable though the goals and objectives may be, 
absolute assays of biologically active substances, with few (if any) 
exceptions, have little useful quantitative meaning (Wells et al,. 1997, 
Batson., 1963, Ramesh, 2008).  
 
Comparative assays: Although absolute assays seldom if ever yield 
adequately reproducible results, it generally is possible to achieve 
experimental quantitation of many biologically active substances through 
assessment of the substance of interest (unknown) in direct comparison 
with a reference substance (standard) qualitatively identical or, at least, 
similar in terms of the response evoked in the test subject of choice (Wells 
et al,. 1997, Batson., 1963). While the absolute potency of either may 
never be known, the comparative or relative activity of the two may be 
assessed and the biological activity of the unknown expressed in relation 
to that of the standard in terms of relative potency, - whether expressed in 
proportions, percentages or in arbitrarily defined units.  
 
By using a common reference or standard substance, various investigators 
may obtain quantitative results with a degree of comparability adequate for 
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their needs. Such relative potency estimates are subject to uncertainty 
(experimental error), of course, but ideally this may be kept within 
manageable proportions. It is this innate element of uncertainty that makes 
bioassay a candidate for statistical consideration (Batson.,1963).  
 
(ii) On the basis of response: On the basis of the response evoked in the test 
subjects of choice, most bioassays may be categorized into one of the 
following types: Direct assays: In these the response in the individual test 
subject is absolute (live, die; response, non-response; etc.) and critical 
(thresh-hold) levels of the assayed material are determinate, at least within 
reasonable limits (Wells et al,. 1997, Batson., 1963). Computations mainly 
involve calculation of means and ratios, and estimation of standard errors 
or confidence limits of such statistics. Example: the cat assay of digitalis. 
Graded response-parallel line assays: In these, the response in the 
individual is proportional to the dose of test substance administered and 
the degree of response is experimentally determinable (Batson., 1963, 
Wells et al,. 1997). Typically, the degree of response is a linear function of 
log-dose and the dosage-response regression lines of "Unknown" and 
"Standard" will be parallel denoting identity or similarity of action. 
Statistical analysis involves mainly regression analysis and analysis of 
variance. With proper design (balanced or partially balanced factorial 
assays), analysis can be simplified greatly through the use of coefficients. 
Example: assay of insulin in the rabbit. Slope-ratio assays: These include 
mainly the microbiological assays, a group of rather limited general 
interest in which the degree of measurable response in the individual 
probably is absolute, but since masses of test subjects (microorganisms) 
are dealt with, the total response measured, as density, acid formation, etc., 
approaches a continuous function. Statistical analysis involves multiple 
regressions and relative potency is estimated from the ratio of the partial 
regression coefficients. Example: microbiological assay of riboflavin. 
Quantal response assays: In these, response in the individual test subject is 
absolute (frequently, live or die) but the critical dose of test material 
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necessary to evoke the response is not directly determinable. Quantitation 
is achieved through the use of groups of test subjects and determination of 
the proportion responding to various dosage levels of "Unknown" and 
"Standard" test products. Following suitable transformation of the data 
(probits, angles, etc.) response typically is a linear function of log dose and 
statistical analysis is essentially similar to that employed with the graded 
response-parallel line bioassays. Examples: mouse-protective potency 
assays of typhoid, pertussis and rabies vaccines (Batson., 1963, Wells et 
al,. 1997, Ramesh, 2008) 
 
The androgen receptor (AR) is involved in the development of male sexual 
characteristics and the estrogen receptor (ER) is involved in female maturation 
and reproductive function. Since estrogens are the most powerful and common 
endocrine disruptors, estrogenic bioassays which identify compounds (chemicals) 
that can interact with the human estrogen receptor are used to assess the presence 
of endocrine disrupting chemicals (Chimento et al 2014).  
 
The estrogenic potential is performed by the application of recombinant yeast 
estrogen screen assay (YES assay) and the reporter gene assay (KBluc assay). The 
two assays are selected based on their different sensitivities and end points. The 
yeast cells contain only one estrogen receptor (ERα), whereas the T47D-KBluc 
cells contain two receptors (both the endogenous ERα and Erß), making the 
KBluc assay more sensitive than the YES assay (Nguyen,. 2010) 
 
There is no significant difference between the sample preparation for bioassays 
and for chemical analysis. For samples preparation procedures that involves 
sample clean up step, has a low risk of positive bias in their analysis. Suspended 
solids must be removed from sample matrices as are adsorbed on to antibodies. If 
good sample preparation and clean-up was performed properly in bioassays. The 
target analytes can be identified without the need for chromatographic separation. 
Some of the hyphenated tandem mass spectrometry GC may require less clean-up 
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procedures because of their selective detection nature of the instrument 
configuration (Chan et al,. 2004). 
 
Table 2: A comparison of chemical and in vitro bioassays applications for 
the analysis of estrogens in water samples (Leusch et al. 2010) 
Chemical applications Bioassays applications 
Both natural and synthetic hormones are 
vigorous; they can cause high endocrine 
effects even at concentration levels 
below the detection limits. 
Because of the sensitive nature of 
bioassays, they have the capability of 
detecting biologically active chemicals 
even at very low concentrations. 
Since the quantification of analytes is 
based on calibration with known 
structural configuration, only targeted 
analysis can be identified and quantified. 
Other bioactive compounds will not be 
detected unless the proper qualitative 
scan has been performed. 
The response of bioassays is based on 
physiological effects in vitro instead of 
the structural orientation of the 
compound. This means that bioassays 
can detect any estrogen independence of 
their chemical behaviour. 
Chemical techniques requires continuous 
improvements in order to measure 
contaminants of major concerns, because 
of the complex nature of chemical 
behaviours of these compounds 
The bioassays respond to modes of 
action. Hence the effects of chemicals 
can be integrated in a mixture. 
Chemical methods provides no 
biological information (such as 
bioavailability) to specify toxicological 
effects which can be used for risk 
assessment. 
Bioassays are the preferred methods for 
the determination of emerging pollutants 
and their methods need not be 
continuously modified to detect 
unknown bioactive contaminants. 
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Chemical analysis does not provide 
toxicity determinations or biological 
changes between the different 
compounds in the matrix. 
Bioassays can inform the exposure 
assessment. 
The nature of potential emerging 
compounds is wide and extensive, given 
that there is a number (thousand) of 
registered chemicals with hundreds of 
them being EDCs. 
Bioassays provide extensive biological 
information which can be used in risk 
assessments and other epidemiological 
studies. 
Can analyse multiple analytes in one 
single analysis 
Only one targeted analyte can be 
analysed at a given time. 
  
 
Some chemical and bioassay analysis have been performed worldwide. In the 
Tiaoxi River, China, only estrone was found, other estrogenic hormones were not 
detected with the HPLC–MS –MS system. The concentration levels of these 
compounds in environmental water samples were in the region of 0 to 17.25 ng/ℓ 
(Tang et al, 2012). In the same study, the estrogenic activity in most of the 
environmental water samples tested positive using the yeast estrogen screen. The 
17β-estradiol equivalent was present in all tested water samples, it was found to 
be 17.60 ng/ℓ particularly in the intake of Taihu Lake. 
 
In a separate work done by Tremblay et al,.(2013) in Hamilton City , estrogenic 
activity was found in the Taupo Gates and Ohaaki Bridge samples at levels close 
to the detection limit of the bioassay and an order of magnitude below the PNEC 
of 2 ng/ℓ estimated for 17β-estradiol (Caldwell et al. 2012).  
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2.6.2 Gas chromatography- mass spectrometry 
 
In gas chromatography (GC) analytes under investigation are subjected into an 
injector port, vaporised and eluted through the capillary n by means of an inert 
carrier gas into the detector. GC is the preferred method of choice when 
compounds that are thermally stable and volatile are to be separated and 
quantified.  
 
The most preferred form of gas chromatography is partition chromatography; the 
Gas-liquid chromatography (GLC) is a form of partition chromatography where 
the separation is based on the partitioning of the components of a chemical 
mixture between a mobile carrier gas and stationary liquid phase supported by the 
solid. The solid sorbent is used as the stationary phase. There is a wide range of 
selective and sensitive detectors with the possibility of hyphenating the gas 
chromatography to mass spectrometer or other detectors to get as much 
information on a sample as possible. (Jager et al,. 2011).  
 
Gas chromatography – mass spectrometry is still the most widely known and 
preferred technique of all hyphenated configurations for GC, and the “marriage” 
of a potent analytical technique with the high level of molecular and structural 
recognition given by the mass spectrometry (MS) has made GC-MS the ideal for 
the analysis of trace organic compounds. This combination allows the use of an 
automated separation on the GC with structural elucidation on the MS in order to 
get the advantages of both. The most common mass analyser is the quadrupole 
mass ion trap or mass filter that allow high scanning speeds up to a transmission 
range of m/z equal 2000 (Perry at al,. 2008). 
 
For structural elucidation, GC can be hyphenated to tandem mass spectrometry (a 
combination of two mass analysers). Tandem mass spectrometry (MS-MS) is an 
instrumentation set up that uses least two stages of mass analysis either in 
conjugation with a dissociation process or a chemical reaction that causes a 
change in the mass or charge of a molecular ion produced. In the most common 
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MS-MS a first mass analyser is used to analyse a precursor ion, which then 
undergoes a fragmentation, either spontaneously or by some activation, to produce 
product ions and neutral fragments. A second mass analyser analyses the product 
ions (Chan et al, 2011) 
Criteria for characterisation must be developed if the single gas chromatography 
mass spectrometer is used especially in sophisticated matrices such as highly 
polluted, treated of untreated waste water samples. These criteria should include 
fragmentation ion, matching of the retention times, presence of at least two 
additional qualifier ions and matching of fragmentation ion ratios within a 
reasonable percentile for other ion for qualitative identification.  
 
A most preferred version of the tandem mass configuration is the ion-trap 
MS/MS. An ion trap itself is like a quadrupole bent on itself in order to form a 
closed loop. A large number of molecules are trapped to induce ionisation hence 
increasing the instrument sensitivity. 
 
The aspect that determines the differentiation between single MS and MS-MS is 
in the selectivity of the analysis. Matrix interferences are the major drawbacks in 
the single MS. This challenge is common for ethynylestradiol, it found that  
concentrations, sometimes are higher than anticipated suggesting that this 
difference may be due to interference by natural organic matter (Grebe et al,. 
2011). 
 
Since steroids are not readily volatile, the analysis is performed following the 
derivatisation step for GC-MS analysis. The process of derivatisation is the major 
disadvantage in the analysis of estrogen hormones when GC is used, it is not only 
tedious to perform but it is laborious and time consuming as well.  
 
In Romanian drinking water, E1 and EE2 were found at an average of 0.40 and 
0.35 ng/ℓ, respectively; α-E2 could only be determined in one sample at 0.30 ng/ℓ, 
while β-E2 was found at an average of 0.70 ng/ℓ. The steroids were found in the 
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lower ng/ℓ range with mean concentrations of 2.5 ng/ℓ E1, 1 ng/ℓ E2 and E2, and 
1.5 ng/ℓ EE2 (Briciu et al,. 2009). 
 
Hua Huang et al,.(2000), using GC-MS following derivatisation, have reported  
the  concentrations  of estrogenic  hormones  17β-estradiol  and  17α-ethinyl-
estradiol discharged by conventional wastewater treatment plants range from 
approx. 0.2 to 4.1 ng/ℓ in Califomia, United State of America. 
 
Recently in Poland, the results of water samples obtained from Brda River 
(Człuchów) showed that estrone, 17β-estradiol, and ethynylestradiol were 
detected (GC-MS analysis following derivatisation) in concentration of 2.2 ± 1.0 
ng/ℓ, 1.8 ± 0.8 ng/ℓ, and 3.6 ± 1.7 ng/ℓ (Woźniak et al,.2014). 
 
2.6.3 Liquid chromatography- mass spectrometry 
 
Unlike gas chromatography where mobile phase is a gas, liquid chromatography 
uses a liquid as a mobile phase. When the separation involves predominantly a 
simple partitioning between two immiscible liquid phases, one stationary and the 
other mobile, the process is called liquid-liquid chromatography (LLC). When 
physical surfaces forces are mainly involved in the retentive ability of the 
stationary phase, the process is denoted liquid-solid (or adsorption) 
chromatography. Liquid chromatography where stationary phase is solid is less 
popular. 
 
In liquid chromatography analytes are introduced into the mobile phase via a loop 
valve and are carried into an analytical column containing distributed stationary 
phase. The species undergo repeated interactions based on the affinity of solutes 
to the stationary phase. The species are gradually separated into bands in the 
mobile phase. At the end of the process, separated components emerge in order of 
increasing interaction with the stationary phase. The least retained component 
emerges first while the most strongly retained components elute last (Jager et al,. 
2011).   
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There are different types of LLC used in the analysis of environmental samples, a 
reverse phase chromatography a normal phase chromatography. In normal phase 
HPLC analytes are separated based on polarity and the interactions between the 
analyte and the stationary phase is purely adsorptive. This type uses polar 
stationary phases (amino, cyano or silica) and a non-polar mobile phase (e.g. 
dichloromethane). It is used when an analyte of interest is relatively polar. 
Equilibration between mobile phase and stationary phase takes long time and 
therefore cannot perform gradient elution, while reverse phase chromatography 
consists of a non-polar stationary phase (C18, C8 etc) and a polar mobile phase 
(methanol – water mixture). It is used when an analyte of interest is non-polar. 
Reverse phase operates on the principle of hydrophobic interactions which results 
from the repulsive forces between a relatively polar solvent, the relatively non 
polar analyte, and the non-polar stationary phase. Reverse phase chromatography 
has been widely used in analytical techniques and is the most popular among the 
liquid chromatographic techniques. 
 
The main advantage of liquid chromatographic techniques in the analysis of 
environmental samples for estrogens is that sulphuric and glucuronic metabolites 
can be determined without the need for derivatisation as it is the case in gas 
chromatographic systems. Most common derivatisation in LC is intended to 
enhance detectability by ultraviolet absorption, fluorescence, or electrochemistry 
(Chan et al,. 2011, (Jager et al,. 2011). In some publications, the use of 
triethylamine or ammonium-acetate for buffering the mobile phase is widely 
documented. A pH-adjustment of the eluent sometimes react with the silica in 
based columns unless the post-column addition of ammonia or trimethylamine is 
used (Ingerslev et al, .2003). 
 
In Mess River during the floodwater season in Luxembourg (11 floods, 66 
samples), the following highest concentrations were reported;- ibuprofen (9–2382 
ng/ℓ), E1 (4–27 ng/ℓ) and diclofenac (3–20 ng/ℓ). The river concentration of E2 
was relatively high (35 ngL
−1
), especially when taking into account its presumed 
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endocrine disrupting effect on animals at this level (Pailler et al, 2009). The 
conditions of SPE followed by LC-MSMS were used to obtain the results.  
 
Vulliet et al,.(2011) reported estrone to be detected in 20% (Out of 21 samples) of 
waters at concentrations generally in the concentration region between  0.1 and 1 
ng/ℓ. Only three out of 21 samples exceeded 1 ng/ℓ of estrone. The presence of 
estrone is common in most hormones analysis because it is the most abundant 
natural estrogen excreted by cycling women, It is also the by-product of 
biodegradation of estradiol (Huerta-Fontela et al,. 2010). 
 
Ethinylestradiol, 17α- and 17β-estradiol were quantified in only few samples. The 
concentrations of ethinylestradiol ranged from 0.5 to 2.6 ng/ℓ, that of 17a-
estradiol from 0.2 to 1.6 ng/ℓ and that of 17b-estradiol from 0.03 to 1.3 ng/ℓ in 
Barcelona, Spain (Vulliet et al,.2011). 
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2.7 Concentration levels of EDCs in water bodies 
 
 
Estrogens have been detected in drinking waters in Germany (up to 2.1 ng/ℓ), 
France (0.2–26.4 ng/ℓ) and Spain (Kuch and Ballschmiter, 2001; Vulliet et al., 
2011; Kuster et al., 2008).  
 
The estrogen such as 17β-Estradiol was detected in groundwater in Austria, in the 
range 0.10 – 0.80 ng/ℓ (Hohenblum et al., 2004), and 11 different hormones in 
France, in the range of 0.30 – 4.0 ng/ℓ even though the fate and impact of these 
compounds is not clearly known on public health. 
 
According to a study performed by Pool et al. (2012), estrone levels above 5 ng/ℓ 
can adversely affect reproduction of aquatic animals. Estrogens are female sex 
hormones which are responsible for the development, reproductive system and 
secondary sex characteristics in females (Martini,. 2006).  
 
Estrone is also the main metabolite of 17-β-estradiol (a natural estrogen) and 
reaches the environment via the sewer system or animal excretion (Ying et al., 
2002; Wenzel et al., 2003). The study conducted in The Netherlands also shows 
that generally, concentrations of hormones in surface water range between 1 and 5 
ng/ℓ with estrone being the most frequent one (Ghambarian et al,. 2012)  
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2.8 Conclusion statement 
 
 
In the literature demonstrates that the availability of certain endocrine disrupters 
in surface water is mainly due to/lack of the following.  
 
 The quantities of some pharmaceuticals in sediments or in the solid phase can 
be expected to be quite high, and therefore an effort should be made to 
quantify this load, either by developing analytical techniques to measure 
pharmaceuticals concentrations in sludge samples or by the determination of 
adsorption coefficients (Kd) to calculate indirectly those concentrations. 
 
 Although there have been reports of the analysis of hormones in the water 
bodies, the literature is still limited and in many developing countries, nothing 
has been reported. Thus the status of these compounds in not known in such 
countries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
 
CHAPTER THREE – OBJECTIVES OF THE STUDY 
 
3.1 Hypothesis of the study 
Estrogenic hormones and their metabolites have polluted Vaal river catchment 
area due to environmental pollution such as industrial pollution and human 
excretion. Some of the indicators of possible pollution by these compounds in the 
Vaal River are increasing number of illegal informal settlements within the 
catchment area and due to inability of waste water treatment plants to cope with 
the influent load of these compounds and to effectively remove these organic 
contaminants during sewage treatment, hence polluting the source water.    
 
 3.2 Aims and the objectives of the Study  
The objectives of this study were to extract, screen available hormones in source 
and potable water supplies, and to develop methodology to separate and quantify 
the amounts of these compounds present in environmental water samples using 
UFLC-MS. 
 
This project has three aims listed as follows;-  
 
 To develop a method suitable for the determination of estrogen 
hormones using UFLC-MS following SPE of water samples from Vaal 
river catchment area, Johannesburg south, South Africa.  
 
 To determine the availability of identified hormones in Drinking water 
samples and in Vaal river catchment area of South Africa. 
 
 To compare the concentrations of these compounds to literature values 
and to any available water standards. 
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3.3  Novelty of the study 
 
 
The study is novel in that although these compounds have been reported in 
literature, not much has been reported in South Africa. There are few results that 
have been reported in literature using UFLC-MS which is the state of the art 
instrumentation. Thus the results are critical in giving an idea of the extent of the 
problem from these compounds.  
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CHAPTER FOUR – RESEARCH METHODOLOGY 
4.1 Sampling 
 
Samples were collected in 1000 mℓ glass amber bottles and transported into the 
laboratory. Samples were extracted immediately to avoid biological degradation. 
A total number of 28 samples of source, surface and drinking water samples were 
collected in 2013 and 2014 periods for hormones analysis. Figure 5 below 
illustrates the map of Vaal dam and Vaal River Catchment area where samples 
were taken for analytical determination. The direction of the flow is from top to 
bottom, Rand water abstract the raw water for purification directly from the Vaal 
dam (Sampling point V1). Table 3 shows the sampling points while Table 4 
indicates the names of hormones of interest in the study. 
A volume of 1000 mℓ of each sample and laboratory prepared spiked standards 
were extracted using solid phase extraction technique and subjected in to the pre-
optimised UFLC – MS-MS. Some sample aliquots were taken to hydrobiology lab 
at the University of Pretoria for estrogenic activity and mutagenicity analysis, see 
results in Table 7.  
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Figure 5:  The Map of Vaal Dam and Vaal River Catchment 
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Table 3:       Sampling points and site description of the collected samples within 
the Vaal catchment areas. 
Sample point Description 
M-A18 Sample point information withheld 
M-A8 Sample point information withheld 
D-DA8 Sample point information withheld 
D-PAL-B4 B4 at Palmiet before chloramination 
M-Canal Raw Canal source water at Zuikerbosch 
M-B12 Sample point information withheld 
D-DB8 DB8 – 5km after chlorination at Zuikerbosch 
D-MAP_S1 S1 at Mapleton after chloramination 
B-RAW Barrage source water 
B-DOM Barrage domestic water 
C-Vaalkop Raw Vaalkop Dam source water to Magalies Water 
D-Townlands 
Purified Water from Magalies Water at 
Rustenburg 
C-VGB 
Vaal River source water at Gladdedrif bridge – 
Villiers 
C-WF Sample point information withheld 
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Table 4:      List of endocrine disrupting compounds monitored 
 
Organic contaminant Classification 
Concern to the Drinking 
Water Industry 
   
17 α Ethinyl estradiol Steroid hormone / 
Synthetic birth control 
pharmaceutical 
Endocrine disruption 
17 α Estradiol Hormone Endocrine disruption 
17 β Estradiol Hormone Endocrine disruption 
Estrone Hormone Endocrine disruption 
   
 
 
4.2 Standards and sample preparation 
 
Estrone (E1, > 99.0%), 17β-Estradiol (E2, > 99.0%), 17α-Estradiol (E3, > 99.0%) 
and 17α-Ethinylestradiol (EE2, > 99.0%) were purchased from Dr Ehrestorfer 
(Johannesburg, South Africa). Methanol (99.9%), GC and HPLC grade was 
purchased from Merck (Johannesburg, South Africa). HPLC grade acetonitrile 
(99.9%) was sourced from B & J (Johannesburg, South Africa). The method blank 
water was prepared in the laboratory by reverse osmosis followed by a milli-Q 
polishing system supplied by Merck South Africa. 
 
The stock standard of each hormone was prepared in 50% v/v (water/methanol) 
by dissolving 10 mg of each pure hormone solid and made it up to a mark in a 10 
mℓ volumetric flask. Further dilutions were made to reach a combined 
concentration of 0.01 ng/µℓ mixed solution. The target analyte concentrations of 
0.2, 0.4, 0.6, 0.8 and 1.0 ng/ℓ were prepared by transferring 20, 40, 60, 80 and 100 
µℓ on 0.01 ng/µℓ mixed solution in to 1000 mℓ of deionised water and extracted 
under optimised conditions of SPE method. Quantities of 1000 mℓ of unknown 
samples were subjected to SPE under the same conditions as calibration standards. 
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The extracts were analysed by UFLC coupled to tandem MS for qualitative and 
quantitative determination of hormones.  
 
4.3 Solid phase extraction procedure 
 
Three aliquots of 10 mℓ methanol were used in sequence to condition the SPE 
(Agela PEP (C18), 200 mg/6 mℓ) cartridges in an already assembled SPE 
manifold.  A volume of 10 mℓ of blank was also added to the cartridge prior to the 
percolation samples and standards. An elution flow rate of 10 mℓ/min was used 
under a carefully controlled vacuum to extract a 1000 mℓ of a sample. 
Vacuum of -20 Hg was used to dry the SPE cartridges containing the analytes 
over a period of 10 to 15 minutes, after the vacuum was switched off the analytes 
were eluted and collected slowly in to the tubes. Methanol was used to elute 
analytes of interest from the SPE cartridges up to a volume of 7.5 mℓ, See Figure 
6 below showing the assembled SPE manifold with conditioned SPE cartridges. 
 
Figure 6:  Assembled SPE manifold with extracting cartridges 
 
45 
 
Nitrogen gas was used to concentrate the 7.5 mℓ of the analyte extract down to the 
volume of less than 150 µℓ before diluting to the 250 µℓ calibration mark with 
50% methanol solution using a calibrated micro-syringe. A concentrate was then 
subjected to a UFLC coupled to a mass spectrometer. These conditions were 
optimum for all analytes of interest in this study. It should also be noted that both 
samples and spiked standards were extracted in the same way using SPE before 
final analysis.  Thus, accuracy of the method in this case is more important than 
recovery as both spiked standards for the calibration curve and samples were 
extracted in the same way. 
 
4.4 Sample analysis 
 
After analytes were subjected to UFLC-MS-MS, the qualitative analysis was 
performed based on retention times of the analytes as well as on the multiple 
reaction monitoring ratios between the precursor and the product ions. The 
quantification was performed using the external calibration method for 
standardisation; the ion of best intensity per each compound was used. The 
introduction of a buffer solution of 0.4% NH3 as a modification agent was 
performed using an external pump system at a flow rate of 0.05 mℓ/min.  
Table 1 shows the list of all hormones determined in this study with an exception 
of estriol due to the absence of the standard. 
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4.5 Detailed instrumental parameters 
 
4.5.1 High Performance Liquid Chromatography 
 
The separation was performed using LC-20AB Shimadzu liquid chromatograph 
connected to SIL-20AC auto-sampler by CBM 20A communication module. The 
temperature of the CTO-10AS column oven was kept constant at 40ºC.  
 
The injection volume used was 100 µℓ for maximum sensitivity while the 
analytical column Kinetex C18- Sorbent (100 x 4.6 mm; 2.6 μm) from 
Phenomenex was used for separation. The mobile phase compositions used for 
analyte elution were acetonitrile (with 5% water in it) and water (with 5% 
Acetonitrile in it) at a flow rate of 0.35 mℓ/min for 12 minutes. The UFLC 
gradient phase program is shown below. 
 
 
Auto sampler parameter  Magnitude 
Injection volume   100 µl 
Rinsing volume   200 µl 
Needle Stroke    52 mm 
Rinsing Speed    35 µl/sec 
Sampling Speed   15.0 µl/sec 
Purge Time    5.0 min 
Rinse Dip Time   0.0 sec 
Rinse mode    before and after aspiration 
Cooler unit at     15⁰C 
Control vial needle stroke  52 mm 
Oven Temp    40⁰C 
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Table 5:  UFLC mobile phase program 
 
Time Parameter (% Water) Parameter (% Acetonitrile) 
0.10 0 100 
8.00 95 5 
9.00 15 85 
12.00 15 85 
12.10 Stop  
 
4.5.2 Mass Spectrometry Conditions 
Table 6 below shows some of the parameters for the AB Sciex 3200 Q Trap mass 
spectrometry system. The instrument was optimised in negative polarity using 
multiple reactions monitoring mode. The variation of coin voltage for each 
compound determined the collision energies (CE), declustering potentials (DP) 
and exit potentials (EP) for these analytes, the actual figures are shown in Table 6 
below. 
Instrument Settings 
Ion source   Turbo Spray 
Scan type   MRM 
Polarity   Negative 
Total Scan time  0.6200 sec 
Table 6:  MRM transitions and retention times 
 
 
R T 
(min) 
Q1 
Mass 
(Da) 
Q3 
Mass 
(Da) 
Time 
(msec) 
Analyte 
Identity 
DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
        
4.12 271.063 144.80 150 17-α-estradiol -70 -70 -2.5 
4.31 271.063 144.801 150 1- β-estradiol -70 -70 -3.5 
4.53 295.064 144.9 150 
17-α-
ethinylestradiol -60 -60 -4 
4.55 269.087 144.9 150 estrone -40 -40 -10 
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4.6 Mass spectrometer optimisation 
 
Physical and chemical properties of hormones are shown in Table 1 above, pKa 
and Log Kow are required as they determine the ionic prevalence of compounds as 
pH changes (Huerta-Fontela et al., 2011). Each 1 mg/ℓ pure hormone standard at a 
pH of 10.2 was infused into the mass spectrometer to optimise fragmentation 
parameters of ions. During the infusion of pure hormones standards, negative and 
positive modes were investigated, the negative mode produced optimum 
conditions as a result it produced intense signals that were used for quantification. 
The negative ionisation was found to be better compared to the positive 
ionisation. The optimisation of cone voltage enhanced the sensitivity of parent 
ions as well as its signal for all analytes.  
The optimised collision energy value differs from analyte to analyte because 
MRM ions were investigated independently within the same compound of 
interest. The different transitions investigated are shown in Table 22. 
 
Figure 7:  A chromatogram of compound mixture dissolved in 50%v/v of 
water/methanol. Where 1, 2, 3 and 4 represent E2 (α), E2 (β), EE2 and E1 
respectively 
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CHAPTER FIVE– RESULTS AND DISSCUSSION 
 
5.1  Results of estrogenic activity and mutagenicity in water 
samples  
 
 
 
Table 7 shows that the estrogenic activity (using T47D-KBluc assay) was detected 
in all the raw water samples however; none of the samples exceeded the trigger 
value of 0.7 ng/ℓ for estrogenic activity in drinking water except sample C-WF in 
dry season.  Cytotoxicity was detected in most (6 out of 12 samples) of the raw 
water samples during the dry season. It is also important to know that this 
cytotoxicity was only detected once the samples were concentrated 100 times 
(Table 7).  It should also be kept in mind that estrogenic activity is a bioassay and 
the activity is measured in estradiol equivalents (Eeq’s) which are only rough 
estimates and not concentrations. The complexity of the sample, pH, and 
extraction procedure of the analysis as well as the nature of the assay can have an 
influence on the results.   
Estrogens (estradiol, estrone, estriol) are female hormones responsible for the 
development and maintenance of reproductive tissues and secondary sex 
characteristics in females (Martini, 2006). Estrone is also the main metabolite of 
17 β estradiol (a natural estrogen) and reaches the environment via the sewer 
system or animal excretion (Ying et al., 2002; Wenzel et al., 2003). 
 
Based on the test criteria of the Ames MPF 98/100 AQUA assay none of the raw 
water samples showed mutagenic activity, the absence of mutagenic effect does 
not mean that the sample was not mutagenic, but rather no mutagenic effect was 
detectable under the assay conditions of the specific test system used. 
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Table 7:  Results of the raw water samples analysed for estrogenic activity 
and mutagenicity. 
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ESTROGENIC ACTIVITY 
Estradiol equivalents  
(YES assay) 
ng/ℓ 0.7 WRC UP  nd nd nd nd nd nd nd nd nd nd nd nd 
Estradiol equivalents  
(T47D-KBluc assay) 
ng/ℓ 0.7 WRC UP 
 
0.16 0.03 0.15 nd 0.18 0.20 0.03 0.07 0.22 0.08 0.15 0.07 
Cytotoxicity ng/ℓ   UP  d nd d d d d nd nd d nd nd nd 
17 a Ethinylestradiol ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd 
17 a Estradiol  ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd 
17 b Estradiol ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd 
Estrone ng/ℓ   RW <0.30 nd nd 0.90 nd nd nd nd nd 4.43 nd nd nd 
MUTAGENICITY 
AMES MPF assay    RW  nd nd nd nd nd nd nd nd nd nd nd nd 
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Table 8:  Results of the drinking water samples analysed for estrogenic activity and mutagenicity 
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Drinking water samples 
M-A8 D-DA8 M-B12 D-DB8 B-DOM 
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Estradiol equivalents  
(YES assay) 
ng/ℓ 0.7 WRC UP  nd nd nd nd nd nd nd nd nd nd nd nd nt nd nd nd 
Estradiol equivalents (T47D-KBluc assay) ng/ℓ 0.7 WRC UP  nd nd 0.02 nd nd nd nd nd nd nd 0.04 nd nt nd 0.03 0.02 
Cytotoxicity ng/ℓ   UP  nd nd nd nd nd d nd nd nd nd nd d nt d nd nd 
17 a Ethinylestradiol ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd nt nd nd nd 
17 a Estradiol  ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd nt nd nd nd 
17 b Estradiol ng/ℓ   RW <0.30 nd nd nd nd nd nd nd nd nd nd nd nd nt nd nd nd 
Estrone ng/ℓ   RW <0.30 nd nd nd nd 2.88 nd nd nd nd nd nd nd nt nd nd nd 
MUTAGENICITY 
AMES MPF assay    RW  nd nd nd nd nd nd nd nd nd nd nd nd nt nd nd nd 
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No anti-estrogenic activity (YES assay) was detected in the drinking water 
samples (Table 8). Also, no estrogenic activity or cytotoxicity was detected in the 
water samples using the YES assay. The estrogenic activity detected by the T47D-
KBluc assay were all well below the trigger value of 0.7 ng/ℓ for estrogenic 
activity in drinking water (Genthe and Steyn, 2008).  The reason why estrogenic 
activity is detected by the KBluc assay and not the YES assay in a specific sample 
could be explained by the fact that the yeast cells contain only the ERα. The 
T47D-KBluc cells contain both the endogenous ERα and ERß, making the T47D-
KBluc assay more sensitive than the YES assay.  
 
It should also be kept in mind that a water sample consists of a complex mixture 
of chemicals with possible (anti)-androgenic and (anti)-estrogenic activity, as well 
as other chemicals not measured, that could affect the outcome of the assay. It 
should therefore be noted that estradiol equivalents are only rough estimates, as 
the complexity of the sample, pH, extraction procedure and the nature of the assay 
(i.e. a biological system) might all have an influence on the results. According to 
Table 8, none of the final water samples showed mutagenic activity based on the 
AMES MPF 98/100 AQUA assay. 
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5.2  Quality Control (QC) and the Analytical Method Validation 
 
 
The overview of the physical and chemical properties of the compounds and some 
quality control parameters are shown below in Table 9. All samples and quality 
control verifications were analysed in the analytical range of up to 1 ng/ℓ. Any 
samples above this range were diluted further accordingly.  
 
Table 9:   Slope, Intercept and Physical and chemical properties of hormones 
(Carpinteiro et al,. 2004, Lewis et al,. 1979) 
 
Analyte *pKa *Log Kow r
2
 Slope Intercept 
E1 10.7 3.7 0.998 18508.6 -318.3 
E2(α) 10.7 4.1 0.997 8658.6 -57.6 
E2(β) 10.7 4.1 0.996 7346.4 14.0 
EE2 10.2 4.5 0.998     5239 -8.0 
 
Table 9 shows the characteristics and method performance parameters, the 
coefficients of determination (r
2
) of more than 0.99 were achieved indicating a 
good linear dynamic range from 0 to 1.0 ng/ℓ. The slope and the intercepts were 
recorded accordingly.  
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The statistical evaluation for 17-α-ethinylestradiol below is an epitome of the 
determination of fundamental figures of merit for the rest of the determinants in 
this study available in Annexure 1, involving the coefficient of determination of 
the calibration function, concentration range, sensitivity, uncertainty of 
measurements and limits of detection and quantification. 
This technique involves a holistic approach to validate the analytical method, 
uncertainty of measurements and accuracy profiles of the analytes.  
Table 10:             Calibration data for 17-α-ethinylestradiol 
  CONCENTRATION (ng/ℓ) RESPONSE RATIO 
0.0 0 
0.2 979 
0.4 2060 
0.6 3320 
0.8 4100 
1.0 5210 
 
Table 10 shows the plot of the concentration of 17-α-ethinylestradiol versus its 
instrument response. These figures were subjected to the data analysis function of 
Microsoft (MS) excel spreadsheet and the following regression summary output 
was obtained.   
REGRESSION ANALYSIS 
  SUMMARY OUTPUT 
 
  Regression Statistics 
Multiple R 0.998806003 
R Square 0.997613431 
Adjusted R Square 0.997016789 
Standard Error 107.1946827 
Observations 6 
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The analysis of variance (ANOVA) was determined using the MS excel to induce 
the slope (sensitivity/x-variable 1), intercept and standard errors that were used for 
the determination of limit of detection and of quantification. 
ANOVA 
       df SS MS F Significance F 
Regression 1 19212984.7 19212984.7 1672.046498 2.13759E-06 
Residual 4 45962.8 11490.7 
  Total 5 19258947.5     
 
  Coefficients Standard Error t Stat P-value Lower 95% 
Intercept -8 77.58181549 -0.103116948 0.922833133 -223.4016519 
X Variable 1 5239 128.1221515 40.89066518 2.13759E-06 4883.275879 
 
The values obtained from the ANOVA for slope (b) and y-intercept was 5239.0 
and -8.0 respectively as coefficients of x and y variables, good linearity was 
reflected by r
2 
value that was closer to 1. 
In order to understand the uncertainty of regression, some of the important 
parameters needed to be deconstructed from the ANOVA in the form of the 
standard errors both from x and y variables. Therefore the regression uncertainties 
of random uncertainty (Sy/x), slope uncertainty (Sb) and Y-intercept uncertainty 
(Sa) were 107.19468270, 128.12215154 and 77.58181549 respectively. 
The slope is the change in analytical response divided by change in concentration 
which is same as sensitivity in any given calibration curve. If the linear calibration 
is assumed, the sensitivity is same as slope (b) at each and every point in the 
analytical concentration x. In addition to that, there are two parameters that can be 
reciprocally derived from sensitivity, the LOD and the LOQ (Gonza´lez et al, 
2007). 
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LOD can be expressed in response units (YLOD) and is taken typically as three 
times the noise level for techniques with continuous recording such as 
chromatography. The LOQ is estimated to be ten times signal to noise ratio hence 
the following calculations. 
Limit of detection 
YLOD=Yb+3Sb=bXLOD+ a 
Assume Yb= a 
Thus, XLOD=3Sb/ b 
Therefore, XLOD= 0.073 ng/ℓ 
 
Limit of quantification 
YLOQ=Yb+10Sb=bXLOQ+ a 
Assume Yb= a 
Thus, XLOQ=10 Sb/ b 
Therefore, XLOQ= 0.245 ng/ℓ 
Accuracy  
Table 11: A spiked quality sample, concentration of 0.50 ng/ℓ 
 
DETERMINATION CONCENTRATION PEAK HEIGHT 
#1 0.43 2240.0 
#2 0.50 2590.0 
#3 0.57 2970.0 
#4 0.52 2690.0 
#5 0.47 2460.0 
#6 0.44 2280.0 
#7 0.49 2520.0 
#8 0.41 2110.0 
Mean 0.48 2482.5 
Std Deviation 0.051 275.875 
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The accuracy of the method was determined by analysing the reproducibility of 
eight replicates on the analyte over a period of time, results in Table 11 were 
obtained. They can be summarised as follows; 
(i)  RSD of concentration, (s x100/mean), % = 10.73 
(ii)  Mean Method Accuracy (% of true conc.), % = 95.6 
(iii)  Method Bias (deviation from true value), % = - 4.4 
Uncertainty of measurements  
The equation of the straight line for the uncertainty of regression can be expressed 
as follows; 
y0=bx0+a  
(Consider Table 11 for a spiked quality sample, concentration of 0.5 ng/ℓ) 
For x0   = 0.4779 
y0   = 2495.587125 
ave.y    = 2482.50000000 
y0-ave.y   = 13.0871 
(y0-ave.y)(y0-ave.y)  = 171.2728408 
 
 
xi xi-ave.x (xi-ave.x)*(xi-ave.x) 
0.0000 -0.500 0.25 
0.2000 -0.300 0.09 
0.4000 -0.100 0.01 
0.6000 0.100 0.01 
0.8000 0.300 0.09 
1.0000 0.500 0.25 
      
 
Sum = 0.7 
 
Sum
2
= 0.49 
 
 
Sx0 =  Sy/x/b {1/m+1/n+ (y0-ave.y)
 2
/b
2
sum(xi-ave.x)
2
}
1/2
 
 
Substitution of the terms above where m and n are number of determination and 
calibration data points respectively resulted in the following answer;- 
Sx0 =  0.022100424 
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The uncertainty of repeatability was obtained by dividing standard deviation of 
y. by its average hence;- 
Std Dev.y/ave.y = 0.111127988 
 
The uncertainty of purity was obtained from the certificate of analysis as 
100±0.5% and was calculated as follows assuming a rectangular distribution;-  
U(P)  = 0.5/3
1/2  
=  0.29 
 
The uncertainty of volume was calculated from all volumetric apparatus used in 
the study taking into account the coefficient of expansion of the volume. 
For the 10 mℓ volumetric flask, the calculation was performed as follows; 
Given 10±0.04mℓ, 20 ±4°C, assuming a rectangular distribution therefore;- 
 
U(V1)  = 0.04/3
1/2 
=  0.023094011 
 
Lab temperature= 20±4°C 
 
Coefficient of volume expansion = 0.00021, assuming rectangular distribution 
therefore;-  
 
 
U(V2)  = Volume variation  = (Volume*temp. var.*coefficient of volume 
expansion)/3
1/2
 
 
  = 0.004849742 
 
 
Volumetric Flask Uncertainty = {U(V1)
2
+U(V2)
2
}
1/2
 
 
Therefore U(VA)/VA   =  0.002359774 mℓ 
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For the 100 µℓ syringe, the calculation was performed as follows; 
Given 100 ±1µℓ at 20 ±4°C, Assuming a rectangular distribution, the calculation 
was performed as follows;- 
 
U(V1)  =1/3
1/2  
= 0.577350269 
 
Lab temperature at 20±4°C 
 
Coefficient of volume expansion = 0.00149, if Assuming a rectangular 
distribution, therefore;- 
 
U(V2)  = Volume variation =   (Volume*temp. var.*coefficient of 
volume expansion)/3
1/2 
 
         =    0.34410076 
 
 
 
Therefore for a 100 µℓ Syringe the Uncertainty  = {U(V1)
2
+U(V2)
2
}
1/2
 
 
U(VB)/VB  =  0.006721151 µℓ 
 
 
 
 
For a 500 µℓ syringe the calculation was performed as follows; 
 
Given a 500 ±1 µℓ, in a room temperature at 20±4°C , Assuming a rectangular 
distribution 
 
U(V1)=1/3
1/2  
=   2.886751346 
 
 
Given a lab temperature of 20±4°C and coefficient of volume expansion of 
0.00149 assuming rectangular distribution, therefore 
 
U(V2)  =    Volume variation=(Volume*temp. var.*coefficient of volume 
expansion)/3
1/2
 
         
=    1.720503802 
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Therefore for a 500 µℓ Syringe the uncertainty = {U(V1)
2
+U(V2)
2
}
1/2
 
 
U(VC)/VC = 0.003360575 µℓ 
 
The uncertainty of the analytical balance was given as U(VD)/VD=  0.002 from the 
calibration certificate. 
 
 
All uncertainty budgets were added and substituted accordingly as per equation 
below;- 
 
x0 =  
 
U(t)/x0 = 
 
(Sx0/x0)
2
+(SR/S)
2
+(U(P)/P)
2
+(U(VA)/VA)
2
+(U(VB)/VB)
2
+(U(VC)/VC)
2
+(U(VD)/VD)
2
}
1/2 
 
U(t) =  0.049235662, this value was multiplied by the coverage factor of 
2.78 for infinite degrees of freedom. 
 
95% CL of x0: x0±{t4;0.05*U(t)} 
 
x0 ± {2.78*U(t)} 
 
= x0 ± 0.14 ng/ℓ, therefore the result of the accuracy of 17-α-ethinylestradiol can 
be expressed as 0.48± 0.14 ng/ℓ. 
 
Similar holistic approach was used when performing statistical evaluation and 
uncertainty of measurement for estrone, 17α-Estradiol and 17 β-Estradiol, the 
final calculations are shown in annexure 1. 
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A QC sample of 0.50 ng/ℓ was prepared by the quantitatively transferring 50 µℓ 
of 0.01 ng/µℓ into 1000 mℓ reagent water using a calibrated micro-syringe.  This 
was extracted in the SPE together with standards and samples under identical 
instrumental conditions. 
In Table 12, the percentage RSDs ranged from 9.3 to 11.4% indicating good 
method precision, the accuracy of the method was in the region of 93.8 to 100.9% 
indicating good performance achieved by the UFLC-MS-MS. The uncertainty of 
measurements was determined using the holistic approach of analytical method 
validation, it ranged between ±0.14 and ±0.15 ng/ℓ. 
 
Table 12:   Method performance parameters obtained from statistical    
evaluation 
 
Analyte Precision 
 
(% RSD) 
Accuracy 
 
(%) 
Uncertainty 
+/- 
(ng/ℓ) 
LOD 
 
 
(ng/ℓ) 
LOQ 
 
 
(ng/ℓ) 
E1  9.3 100.9 0.15 0.07     0.30 
E2(α) 9.6 93.8 0.14 0.09 0.30 
E2(β) 11.4 97.6 0.15 0.10 0.32 
EE2 10.7 95.6 0.14 0.07 0.24 
 
nd – is applicable to analytes not detected. 
 
Table 12 also gives a summary for the evaluation of LOD and LOQ in 
quantitative chemical analysis, based on the approach taken in the ISO “Guide to 
the Expression of Uncertainty in Measurement” (Ellison et al,.2011). Uncertainty 
of measurements was applied to at all levels of analytical results, detailed 
calculations were performed in Microsoft excel spread sheet as expressed in 
Annexure 1. 
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 The recovery of spiked samples was not determined since calibration standards 
and analytical samples were extracted in the similar manner. Analysis was 
performed under similar SPE and optimised instrumental conditions. Instead of 
using recovery to measure accuracy, the quality control sample, internally 
prepared in the laboratory, analysed independently over a period of three non-
consecutive days was used to determine the accuracy of the method. 
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5.3  Optimisation of the analytical method 
 
 
Following the understanding of the effects of pKa and Log Kow in relation to their 
ionic prevalence (Huerta-Fontela et al., 2011), each 1 mg/ℓ pure hormone 
standard at a pH of 10.2 was infused into the mass spectrometer to optimise 
fragmentation parameters of ions. Various parameters of the mass spectrometer 
were explored, negative mode produced optimum conditions as a result it 
produced intense signals that were used for quantification, See Annexure 3. 
 Two transition ions were selected; the more intense fragmentation ion was used 
for quantification of analytes and less intense one for confirmation. It was 
therefore equally important to have transition ions that are stable and intense. The 
mass spectrometer was optimised by investigating the change in collision energy 
versus the production of the product ion (MRM 1 and 2) formed after each parent 
ion was fragmented. There was a direct correlation between the collision energy 
variation’s influence on the precursor ion and the production of product ions.  
The co-elution of peaks existed when the mixture of hormones was analysed. The 
co-elution of isomers 17β-Estradiol (β-E2) and 17α -Estradiol (α-E2) was due to 
similar chemical properties. Analytical gradient conditions were further optimised 
to achieve the separation of two peaks at 4.12 and 4.31 minutes (Figure 7). The co 
elution of E1 and EE2 at 4.53 minutes was insignificant since their product ions 
are different.  Details of the separation for the four compounds are shown along 
with their fragmentation ions (Refer to Figure 26 for the detailed transition 
profiles of parent and product ions). 
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Figure 8: Retention Time 4.12,  17-α- estradiol 
 
 
Figure 9: Retention Time 4.31,  17-β- estradiol 
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Figure 10: Retention Time 4.53, 17-α-ethinylestradiol 
 
 
Figure 11: Retention Time 4.55, Estrone 
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5.4  Analysis of hormones in environmental water samples 
 
 
 
To the best of our knowledge, this is the first time that hormones are investigated 
in Vaal Rivers’ catchments, raw and treated waters in South Africa. This is also 
one of few studies of these compounds in South African aquatic ecosystem. 
Regarding water analysis, earlier studies have shown that these compounds are 
only partially eliminated during conventional (coagulation, sand filtration) water 
treatment (Huerta-Fontela et al., 2011). 
 
There is little information about the occurrence of hormones in ground waters and 
drinking waters for public health issues. Hohenblum et al. (2004) detected 17β-
Estradiol in the range 0.1 to 0.8 ng/ℓ in Austrian groundwater. Various estrogenic 
compounds were detected in ground and surface waters water of France within the 
range of 0.1 to 1 ng/ℓ even though the fate and impact of these compounds are not 
clearly known on public health (Vulliet and Cren-Olivé, 2011). 
 
 After the method development, here we further conducted a study between 2013 
and 2014 periods where samples were taken in summer (wet season) as well as in 
winter (dry season); a total combined number of 28 samples were taken for 
endocrine disrupting compound determination in both seasons. The bi-annual 
assessment results for the wet and dry seasons of raw water samples are presented 
in Table 7. 
No estrogen hormone was detected in any of the eight drinking water samples in 
the south of Johannesburg region during both seasons with an exception of one 
sample at a concentration of 2.88 ng/ℓ estrone. According to a study conducted by 
Dévier et al. (2013) these four estrogenic hormones were also not detected in 
Evian and Volvic (bottled natural mineral waters), the presence of this hormone in 
treated water however came as a surprise and has not yet been established. 
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However, estriol has been detected at the drinking water treatment plant of Abrera 
in Spain at a concentration of 11.60 ng/ℓ (Kuster et al., 2008).  
 
Table 13:  Summary of results for the raw water samples where the hormones 
of interest were detected 
 
Parameter 
Unit of 
measure 
Raw water samples 
Sample B Sample E 
Wet 
season 
Dry 
season 
Wet 
season 
Dry 
season 
E1 ng/ℓ 0.90 nd 4.43 nd 
E2(α) ng/ℓ nd nd nd nd 
E2(β) ng/ℓ nd nd nd nd 
EE2 ng/ℓ nd nd nd nd 
nd – is applicable to analytes not detected. 
 
The endocrine disruptor estrone was detected during the wet season in Sample B 
and Sample E which are raw water samples at a concentration of 0.90 and 4.43 
ng/ℓ respectively (Table 13).   According to a study performed by Pool et al. 
(2012) estrone levels above 5 ng/ℓ can adversely affect reproduction of aquatic 
animals.  
The availability of estrone in water bodies did not come as a surprise because it is 
also the main metabolite of 17β-Estradiol (a natural estrogen) and reaches the 
environment via the sewer system or animal excretion (Wenzel et al., 2003).  
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Table 14:  Summary of availability of hormones in South Africa compares to 
other countries surface waters 
 
Country α -E2 
(ng/ℓ) 
β-E2 
(ng/ℓ) 
EE2 
(ng/ℓ) 
E1 
(ng/ℓ) 
Reference 
Netherlands 0.3 – 3.0 0.3 – 5.5 0.1 – 4.3 0.1 – 3.4 Belfroid et 
al.,1999 
China 0 – 1.8 - 0 – 2.7 0.5 – 3.1 Jiang et 
al.,2011 
German - - - 0 – 1.6 Ternes et 
al.,1999 
South Korea - - - 1.8 – 5.0 Kim et 
al.,2007 
South Africa - - - 0.9 - 4.4 This Study 
 
A study conducted in the Netherlands also shows that generally, concentrations of 
hormones in surface water range between 1 and 5 ng/ℓ with estrone being the 
most frequent observed estrogen hormone.  
 
During the Vaal River catchment study the concentration level of estrone was 
detected in the range of 0.90 to 4.43 ng/ℓ which is not significantly different from 
the result of 1 to 5 ng/ℓ obtained in the Netherlands and in other countries (Table 
14). Guang-Guo Ying et al. (2002) reported that estrogens in humans and animals 
undergo various degradation mechanisms taking place mainly in the liver. They 
are frequently oxidized, hydroxylated, deoxylated and methylated prior to the 
final conjugation with glucuronic acid or sulphate. E2 is rapidly oxidized to 
estrone, which can be further converted into estriol, the major excretion product 
which has not been determined in this study. A study performed on Canadian and 
German waste water samples detected estrone at a maximum concentration level 
of 70 ng/ℓ. However, a concentration of 1.6 ng/ℓ estrone was detected in the 
surface and stream water samples in Germany (Ternes et al., 1999). This can 
support the rapid degradation of estrone into estriol (Guang-Guo Ying et al. 
2002).     
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CHAPTER SIX – CONCLUSION AND RECOMMENDATIONS 
 
6.1 Conclusions   
 
A sensitive analytical method has been developed and validated to identify and 
quantify four hormones in raw and treated drinking water samples with the 
accuracy ranging between 93.8 – 100.9% and the limit of quantification in the 
range of 0.24 - 0.32 ng/ℓ for all analytes. 
 
The study reveals that in South Africa the occurrence of hormones in raw water is 
variable depending on the particular season, the absence of hormones in drinking 
water reveals that current levels of hormones are removed during conventional 
water treatment processes.  
 
Based on method statistical analysis the high accuracy, good precision, limits of 
detection, limits of quantification and overall good performance in terms of 
consistency in results obtained by SPE and UFLC interfaced to a MS-MS, 
Consequently the evidence demonstrates that the developed method is suitable for 
determination of estrogen hormones in source and drinking water samples. 
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6.2 Recommendations 
 
It is recommended that the method for wastewater effluents be developed and 
validated to determine the availability of these compounds in water treatment 
plants of South Africa. The application of the developed methods to other waste, 
raw water and drinking water sources in the country is required in order to 
establish a high priority list of estrogens to be monitored and regulated. This will 
be followed by necessary studies for the removal of these contaminants if they are 
available in large quantities in South African water streams. 
 
The second recommendation is to perform qualitative analysis of other classes of 
emerging contaminants such as PPCPs. In determining these contaminants, the 
inside out approach should be used, whereby screening can be done in all source 
water points and the list compiled with the identified contaminants. This priority 
list should then be compared with the international data available in the literature. 
The criteria for monitoring should be triggered by relevance, toxicological effects, 
national interest (SA) and legislation in order to develop a nationwide monitoring 
framework for endocrine disrupting compounds. 
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CHAPTER SEVEN– PRESENTATIONS AND PUBLICATIONS 
 
7.1 Conference Presentations  
 
SB Mnguni, C Schoeman, SS Marais, E Cukrowska, L Chimuka  Determination 
of Estrogen Hormones in Raw and Treated Water Samples by Reverse Phase 
Ultra-Fast Liquid Chromatography Mass Spectrometry. SACI Convention 2015. 
29
th
 – 04th December 2015. Elangeni Hotel, Durban (South Africa) 
 
 
S. Mnguni, L. Chimuka. Determination of estrogen hormones in raw and treated 
water samples by reverse phase ultra-fast liquid chromatography mass 
spectrometry. Chromsa Postgraduate Seminar 2015. 11
th
 August 2015. University 
of the Witwatersrand, Johannesburg (South Africa) 
 
S. Mnguni, L. Chimuka, C. Schoeman. Determination of Endocrine Disrupting 
Compounds such as hormones in environmental samples by HPLC-MS. NLA 
Test and Measurement Conference. 20
th
 October 2013. Misty Hills Conference 
Hotel, Muldersdrift (South Africa) 
http://www.nla.org.za/conferences/proceedings_archive/2013/Presentations/Tuesd
ay,%208%20October/T107%20Determination%20of%20endocrine%20disruptive
%20compounds%20such%20as%20hormones%20in%20environmental%20water
%20samples%20by%20HPLC-MS.pdf  
 
http://www.nla.org.za/conferences/proceedings_archive/2013/Manuscripts/Tuesda
y,%208%20October/T107%20Determination%20of%20Endocrine%20Disrupting
%20Compounds%20such%20as%20Hormones%20in%20Environmental%20Wat
er%20Samples%20by%20HPLC-M.pdf  
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7.2 Publications emanating from this project  
 
SB Mnguni
1*
, C Schoeman
1
, SS Marais
1
, E Cukrowska
2
, L Chimuka
2
  
Determination of Estrogen Hormones in Raw and Treated Water Samples by 
Reverse Phase Ultra-Fast Liquid Chromatography Mass Spectrometry – a Case 
Study in Johannesburg South, South Africa. (Submitted to Water SA), Review 
number - Water SA 3251 
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ANNEXTURES 
Annexure 1: Statistical analysis and uncertainty of measurements calculations 
Table 15 : Analysis of Variance of 17-a-ethinylestradiol 
 
17 a ethinylestradiol 
    
       
       
       1. RANGE OF STANDARDS 
     0-1.0 ng/ℓ 
      
       
       
       2. CALIBRATION DATA 
     
       CONCENTRATION 
(ng/ℓ) 
RESPONSE RATIO 
     
     0.0 0 
     0.2 979 
     0.4 2060   
    0.6 3320   
    0.8 4100   
    1.0 5210   
        
     
       
        
3. REGRESSION ANALYSIS      
       SUMMARY OUTPUT 
     
       Regression Statistics 
     Multiple R 0.998806003 
     R Square 0.997613431 
     Adjusted R Square 0.997016789 
     Standard Error 107.1946827 
     Observations 6 
     
       ANOVA 
        df SS MS F Significance F 
 Regression 1 19212984.7 19212984.7 1672.046498 2.13759E-06 
 Residual 4 45962.8 11490.7 
   Total 5 19258947.5       
 
         Coefficients Standard Error t Stat P-value Lower 95% Upper 95% 
Intercept -8 77.58181549 -0.103116948 0.922833133 -223.4016519 207.40165 
X Variable 1 5239 128.1221515 40.89066518 2.13759E-06 4883.275879 5594.7241 
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4.1 Slope (b)  5239.00000000     
 
4.2 Y-intercept (a)  -8.00000000  
    
4.3 Linearity 
 
Fcalc   = 1672 
   
  
Fcalc large , therefore signifigant linearity 
  
       
5. REGRESSION UNCERTAINTIES      
       5.1 Random Uncertainty (Sy/x) 107.19468270 
    5.2 Slope Uncertainty (Sb) 128.12215154 
    5.3 Y-intercept Uncertainty (Sa) 77.58181549 
    
       
       
       
 
6. LIMIT OF DETECTION      
       YLOD=YB+3SB=bXLOD+a 
     Assume YB=a 
      Thus, XLOD=3Sb/b,ng/ℓ 
     0.073 ng/ℓ 
     
       
       
6. LIMIT OF QUANTITATION      
       YLOQ=YB+10SB=bXLOQ+a 
     Assume YB=a 
      Thus, XLOQ=10Sb/b,ng/ℓ 
     0.245 ng/ℓ 
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7. ACCURACY       
A spiked quality sample, concentration of  
 
0.5 mg/L 
 
       DETERMINATION CONCENTRATION PEAK HEIGHT 
    #1 0.43 2240.0 
    #2 0.50 2590.0 
    #3 0.57 2970.0 
    #4 0.52 2690.0 
    #5 0.47 2460.0 
    #6 0.44 2280.0 
    #7 0.49 2520.0 
    #8 0.41 2110.0 
    Mean 0.48 2482.5 
    Std Deviation 0.051 275.875 
    
       7.1 RSD of concentration, ( sx100/mean), % 
    10.73 
      
       7.2 Mean Method Accuracy (% of true conc.), % 
    95.6 
      
       7.3 Method Bias (deviation from true value), % 
    -4.4 
      
       
8. UNCERTAINTY       
       8.1 Uncertainty of Regression 
     
       y0=bx0+a 
      For x0= 0.4779 
     y0= 2495.587125 
     ave.y = 2482.50000000 
     y0-ave.y = 13.0871 
     (y0-ave.y)(y0-ave.y) 171.2728408 
     
       
xi xi-ave.x (xi-ave.x)*(xi-ave.x) 
    0.0000 -0.500 0.25 
    0.2000 -0.300 0.09 
    0.4000 -0.100 0.01 
    0.6000 0.100 0.01 
    0.8000 0.300 0.09 
    1.0000 0.500 0.25 
          
    
 
Sum = 0.7 
    
 
Sum
2
= 0.49 
    
       Sx0= Sy/x/b{1/m+1/n+(y0-ave.y)
2/b2sum(xi-ave.x)
2}1/2 
  
m = determinations = 1 
     
n = calibration points =6 
95 
 
 
Sx0= 0.022100424 
     
      
8.2 Uncertainty of Repeatability 
     Std Dev.y/ave.y= 0.111127988 
     
       8.3 Uncertainty of Purity 
     Purity=100%+-0.5% 
      Assume rectangular distribution 
     U(P)=0.5/31/2= 0.29 
     
       8.4 Uncertainty of Volume 
     
       8.4.1 10mℓ  volumetric flask, S.N 0134 
     10mℓ +-0.04mℓ , 20DC 
     Assume rectangular distribution 
     U(V1)=0.04/3
1/2= 0.023094011 
     Lab temperature= 20DC+- 4 
    Coefficient of volume expansion= 0.00021 
    Assume rectangular distribution 
     U(V2)= Volume variation= (Volume*temp. var.*coefficient of volume expansion)/3
1/2 
  
 
0.004849742 
     Volumetric Flask Uncertainty= {U(V1)
2+U(V2)
2}1/2 
    
 
U(VA)/VA= 0.002359774 mℓ  
   
       8.4.2 100ul syringe 
     100ul+-1ul, 20DC 
      Assume rectangular distribution 
     U(V1)=1/3
1/2= 0.577350269 
     Lab temperature= 20DC+- 4 
    Coefficient of volume expansion= 0.00149 
    Assume rectangular distribution 
     U(V2)= Volume variation= (Volume*temp. var.*coefficient of volume expansion)/3
1/2
 
  
 
0.34410076 
     100ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
    
 
U(VB)/VB= 0.006721151 ul 
   
       8.4.3 500ul syringe 
     500ul+5ul, 20DC 
      Assume rectangular distribution 
     U(V1)=5/3
1/2
= 2.886751346 
     Lab temperature= 20DC+- 4 
    Coefficient of volume expansion= 0.00149 
    Assume rectangular distribution 
     U(V2)= Volume variation= (Volume*temp. var.*coefficient of volume expansion)/3
1/2 
  
 
1.720503802 
     500ul Syringe Uncertainty= {U(V1)
2
+U(V2)
2
}
1/2
 
    
 
U(VC)/VC= 0.003360575 ul 
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8.5 Uncertainty of Balance 
     
       
       
 
U(VD)/VD= 0.002 g 
   
       8.6 Total Uncertainty, at x0= 0.5 
    U(t)/x0= {(Sx0/x0)
2+(SR/S)2+(U(P)/P)2+(U(VA)/VA)
2+(U(VB)/VB)
2+(U(VC)/VC)
2+(U(VD)/VD)2}1/2 
  U(t)= 0.049235662 ng/ℓ 
    
       95% CL of x0: x0+/-{t4;0.05*U(t)} 
     
 
x0+/-{2.78*U(t)} 
     
 
0.5 ng/ℓ      +/- 0.1 ng/ℓ 
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Table 16: Analysis of Variance of 17-a-ethinylestradiol 
 
17 a estradiol 
      
         
         
         1. RANGE OF STANDARDS 
       0-1.0 ng/ℓ 
        
         
    
 
     
         2. CALIBRATION DATA 
       
         CONCENTRATION 
(ng/ℓ) 
RESPONSE 
RATIO        
       0.0 0 
       0.2 1640 
       0.4 3220   
      0.6 5180   
      0.8 7190   
      1.0 8400   
          
       
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
98 
 
 
 
 
        
3. REGRESSION ANALYSIS        
         SUMMARY OUTPUT 
       
       
K 6 
Regression Statistics 
     
sum(x) 3.0000 
Multiple R 
0.9982507
58 
     
    
R Square 
0.9965045
76 
     
sum(x)2 2.2 
Adjusted R 
Square 
0.9956307
2 
     
    
Standard 
Error 
214.52383
59 
     
    
Observations 6 
     
SS(X) 0.7 
       
sumY 25630 
ANOVA 
      
sum(y)2 
16214650
0 
  df SS MS F 
Significan
ce F 
 
SS(Y) 
52663683
.33 
Regression 1 
52479601.
43 
52479601.
43 
1140.353
29 
4.58709E-
06 
 
sumXY 18876 
Residual 4 
184081.90
48 
46020.476
19 
   
SP(XY) 6061 
Total 5 
52663683.
33       
 
B (SLOPE) 
8658.571
429 
         
  
Coefficien
ts 
Standard 
Error t Stat P-value 
Lower 
95% 
Upper 
95% 
Lower 
95.0% 
Upper 
95.0% 
Intercept 
-
57.619047
62 
155.26095
36 
-
0.3711109
99 
0.729374
349 
-
488.69256
23 
373.454
47 
-
488.6925
62 
373.4544
671 
X Variable 1 
8658.5714
29 
256.40502
61 
33.769117
4 
4.58709E
-06 
7946.6769
49 
9370.46
59 
7946.676
95 
9370.465
908 
         
         
         
         
4.1 Slope (b)   8658.57142857     
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4.2 Y-intercept (a)  -57.61904762     
  
4.3 Linearity 
 
Fcalc   = 1140 
     
  
Fcalc large , therefore signifigant linearity 
    
         5. REGRESSION UNCERTAINTIES        
         5.1 Random Uncertainty (Sy/x) 214.52383595 
      5.2 Slope Uncertainty (Sb) 256.40502611 
      5.3 Y-intercept Uncertainty (Sa) 155.26095362 
      
         
         
         
6. LIMIT OF DETECTION        
         YLOD=YB+3SB=bXLOD+a 
       Assume YB=a 
        Thus, XLOD=3Sb/b,ng/ℓ 
       0.089 ng/ℓ 
       
         
         
6. LIMIT OF QUANTITATION        
         YLOQ=YB+10SB=bXLOQ+a 
       Assume YB=a 
        Thus, XLOQ=10Sb/b,ng/ℓ 
       0.296 ng/ℓ 
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7. ACCURACY         
A spiked quality sample, concentration of  
 
0.5 mg/L 
   
         DETERMINATION CONCENTRATION PEAK HEIGHT 
      #1 0.5 3880.0 
      #2 0.4 3800.0 
      #3 0.5 4640.0 
      #4 0.5 3920.0 
      #5 0.5 4140.0 
      #6 0.4 3330.0 
      #7 0.5 4330.0 
      #8 0.4 3770.0 
      Mean 0.5 3976.3 
      Std Deviation 0.045 395.725 
      
         7.1 RSD of concentration, ( sx100/mean), % 
      9.55 
        
         7.2 Mean Method Accuracy (% of true conc.), % 
      93.8 
        
         7.3 Method Bias (deviation from true value), % 
      -6.2 
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8. UNCERTAINTY         
         8.1 Uncertainty of Regression 
       
         y0=bx0+a 
        For x0= 0.4690 
       y0= 4003.250952 
       ave.y = 3976.25000000 
       y0-ave.y = 27.0010 
       (y0-ave.y)(y0-
ave.y) 729.0514295 
       
         xi xi-ave.x (xi-ave.x)*(xi-ave.x) 
      0.0000 -0.500 0.25 
      0.2000 -0.300 0.09 
      0.4000 -0.100 0.01 
      0.6000 0.100 0.01 
      0.8000 0.300 0.09 
      1.0000 0.500 0.25 
            
      
 
Sum = 0.7 
      
 
Sum2= 0.49 
      
         
Sx0= 
Sy/x/b{1/m+1/n+(y0-ave.y)
2/b2sum(xi-
ave.x)2}1/2 
  
m = determinations 
= 1 
  
     
n = calibration 
points =6 
  
 
Sx0= 0.02676125 
      
         8.2 Uncertainty of Repeatability 
       Std 
Dev.y/ave.y= 0.099522143 
       
         8.3 Uncertainty of Purity 
       Purity=100%+-
0.5% 
        Assume rectangular distribution 
       U(P)=0.5/31/2= 0.29 
       
         8.4 Uncertainty of Volume 
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8.4.1 10mℓ  volumetric flask, S.N 
0134 
       10mℓ +-0.04mℓ , 20DC 
       Assume rectangular distribution 
       U(V1)=0.04/3
1/2
= 0.023094011 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00021 
      Assume rectangular distribution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
0.004849742 
       Volumetric Flask Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VA)/VA= 0.002359774 mℓ  
     
         8.4.2 100ul syringe 
       100ul+-1ul, 
20DC 
        Assume rectangular distribution 
       U(V1)=1/3
1/2= 0.577350269 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distribution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
0.34410076 
       100ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VB)/VB= 0.006721151 ul 
     
         8.4.3 500ul syringe 
       500ul+-5ul, 
20DC 
        Assume rectangular distribution 
       U(V1)=5/3
1/2= 2.886751346 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distribution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
1.720503802 
       500ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VC)/VC= 0.003360575 ul 
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         8.5 Uncertainty of Balance 
       
         
         
 
U(VD)/VD= 0.002 g 
     
         8.6 Total Uncertainty, at x0= 0.5 
      
U(t)/x0= 
{(Sx0/x0)
2+(SR/S)2+(U(P)/P)2+(U(VA)/VA)
2+(U(VB)/VB)
2+(U(VC)/VC)
2+(U(VD)
/VD)2}1/2 
    U(t)= 0.051194144 ng/ℓ 
      
         95% CL of x0: x0+/-{t4;0.05*U(t)} 
       
 
x0+/-{2.78*U(t)} 
       
 
0.5 ng/ℓ      +/- 0.1 ng/ℓ 
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Table 17: Analysis of Variance of 17-b-estradiol 
 
17 b estradiol 
      
         
         
         1. RANGE OF STANDARDS 
       0-1.0 ng/ℓ 
        
         
   
 
     
         2. CALIBRATION DATA 
       
         CONCENTRATION 
(ng/ℓ) 
RESPONSE 
RATIO        
       0.0 33 
       0.2 1290 
       0.4 3260   
      0.6 4360   
      0.8 5770   
      1.0 7410   
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3. REGRESSION ANALYSIS        
         SUMMARY OUTPUT 
       
       
K 6 
Regression Statistics 
     
sum(x) 3.0000 
Multiple R 
0.997978
582 
     
    
R Square 
0.995961
25 
     
sum(x)2 2.2 
Adjusted R 
Square 
0.994951
563 
     
    
Standard 
Error 
195.7011
236 
     
    
Observations 6 
     
SS(X) 0.7 
       
sumY 22123 
ANOVA 
      
sum(y)2 
11950339
5.6 
  df SS MS F 
Significanc
e F 
 
SS(Y) 
37931470
.01 
Regression 1 
37778274.
29 
37778274
.29 
986.4054
825 
6.12507E-
06 
 
sumXY 16204 
Residual 4 
153195.71
9 
38298.92
976 
   
SP(XY) 5142.45 
Total 5 
37931470.
01       
 
B (SLOPE) 
7346.357
143 
         
  
Coefficien
ts 
Standard 
Error t Stat P-value 
Lower 
95% 
Upper 
95% 
Lower 
95.0% 
Upper 
95.0% 
Intercept 
14.00476
19 
141.63807
45 
0.098877
099 
0.925992
834 
-
379.24557
69 
407.255
1 
-
379.2455
77 
407.2551
007 
X Variable 1 
7346.357
143 
233.90758
18 
31.40709
287 
6.12507E-
06 
6696.9255
82 
7995.78
87 
6696.925
58 
7995.788
703 
         
         
         
         
4.1 Slope (b)   7346.35714286     
  
 
4.2 Y-intercept (a)  14.00476190   
     
4.3 Linearity 
 
Fcalc   = 986 
     
  
Fcalc large , therefore signifigant linearity 
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5. REGRESSION UNCERTAINTIES        
         5.1 Random Uncertainty (Sy/x) 195.70112356 
      5.2 Slope Uncertainty (Sb) 233.90758176 
      5.3 Y-intercept Uncertainty (Sa) 141.63807455 
      
         
         
         
6. LIMIT OF DETECTION        
         YLOD=YB+3SB=bXLOD+a 
       Assume YB=a 
        Thus, XLOD=3Sb/b,ng/ℓ 
       0.096 ng/ℓ 
       
         
         
6. LIMIT OF QUANTITATION        
         YLOQ=YB+10SB=bXLOQ+a 
       Assume YB=a 
        Thus, XLOQ=10Sb/b,ng/ℓ 
       0.318 ng/ℓ 
       
         
         
         
         
         
         
7. ACCURACY         
A spiked quality sample, concentration of  
 
0.5 mg/L 
   
         DETERMINATION CONCENTRATION PEAK HEIGHT 
      #1 0.5 3500.0 
      #2 0.5 3750.0 
      #3 0.6 4320.0 
      #4 0.5 3360.0 
      #5 0.5 3870.0 
      #6 0.4 3170.0 
      #7 0.5 3620.0 
      #8 0.4 2990.0 
      Mean 0.5 3572.5 
      Std Deviation 0.056 419.651 
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7.1 RSD of concentration, ( sx100/mean), % 
      11.39 
        
         7.2 Mean Method Accuracy (% of true conc.), % 
      97.6 
        
         7.3 Method Bias (deviation from true value), % 
      -2.4 
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8. UNCERTAINTY         
         8.1 Uncertainty of Regression 
       
         y0=bx0+a 
        For x0= 0.4879 
       y0= 3598.108753 
       ave.y = 3572.50000000 
       y0-ave.y = 25.6088 
       (y0-ave.y)(y0-
ave.y) 655.808229 
       
         
xi xi-ave.x 
(xi-ave.x)*(xi-
ave.x) 
      0.0000 -0.500 0.25 
      0.2000 -0.300 0.09 
      0.4000 -0.100 0.01 
      0.6000 0.100 0.01 
      0.8000 0.300 0.09 
      1.0000 0.500 0.25 
            
      
 
Sum = 0.7 
      
 
Sum2= 0.49 
      
         
Sx0= 
Sy/x/b{1/m+1/n+(y0-ave.y)
2/b2sum(xi-
ave.x)2}1/2 
  
m = determinations 
= 1 
  
     
n = calibration 
points =6 
  
 
Sx0= 0.028773937 
      
         8.2 Uncertainty of Repeatability 
       Std 
Dev.y/ave.y= 0.1174671 
       
         8.3 Uncertainty of Purity 
       Purity=100%+-
0.5% 
        Assume rectangular distrobution 
       U(P)=0.5/31/2= 0.29 
       
         8.4 Uncertainty of Volume 
       
         8.4.1 10mℓ  volumetric flask, S.N 
0134 
       10mℓ +-0.04mℓ , 20DC 
       Assume rectangular distrobution 
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U(V1)=0.04/3
1/2
= 0.023094011 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00021 
      Assume rectangular distrobution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
0.004849742 
       Volumetric Flask Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VA)/VA= 0.002359774 mℓ  
     
         8.4.2 100ul syringe 
       100ul+1ul, 
20DC 
        Assume rectangular distrobution 
       U(V1)=1/3
1/2= 0.577350269 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distrobution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
0.34410076 
       100ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VB)/VB= 0.006721151 ul 
     
         8.4.3 500ul syringe 
       500ul+-5ul, 
20DC 
        Assume rectangular distrobution 
       U(V1)=5/3
1/2= 2.886751346 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distrobution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
1.720503802 
       500ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VC)/VC= 0.003360575 ul 
     
         8.5 Uncertainty of Balance 
       
         
         
 
U(VD)/VD= 0.002 g 
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         8.6 Total Uncertainty, at x0= 0.5 
      
U(t)/x0= 
{(Sx0/x0)
2+(SR/S)2+(U(P)/P)2+(U(VA)/VA)
2+(U(VB)/VB)
2+(U(VC)/VC)
2+(U(VD)/
VD)2}1/2 
    U(t)= 0.054138708 ng/ℓ 
      
         
95% CL of x0: 
x0+/-
{t4;0.05*U(t)} 
       
 
x0+/-{2.78*U(t)} 
       
 
0.5 ng/ℓ      +/- 0.2 ng/ℓ 
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Table 18: Analysis of Variance of estrone 
 
estrone 
      
         
         
         
1. RANGE OF STANDARDS 
  
 
     0-1.0 ng/ℓ 
        
         
         
         2. CALIBRATION DATA 
       
         CONCENTRATION 
(ng/ℓ) 
RESPONSE 
RATIO        
       0.0 36 
       0.2 3240 
       0.4 6640   
      0.6 11000   
      0.8 14200   
      1.0 18500   
          
       
         
          
 
 
 
3. REGRESSION ANALYSIS        
         SUMMARY OUTPUT 
       
       
K 6 
Regression Statistics 
     
sum(x) 3.0000 
Multiple R 
0.9988159
6 
     
    
R Square 
0.9976333
23 
     
sum(x)2 2.2 
Adjusted R 
Square 
0.9970416
53 
     
    
Standard 
Error 
377.11688
22 
     
    
Observations 6 
     
SS(X) 0.7 
       
sumY 53616 
ANOVA 
      
sum(y)2 
71947849
6 
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  df SS MS F 
Significan
ce F 
 
SS(Y) 
24036592
0 
Regression 1 
239797051
.4 
23979705
1.4 
1686.133
237 
2.10209E-
06 
 
sumXY 39764 
Residual 4 
568868.57
14 
142217.14
29 
   
SP(XY) 12956 
Total 5 240365920       
 
B (SLOPE) 
18508.57
143 
         
  
Coefficien
ts 
Standard 
Error t Stat P-value 
Lower 
95% 
Upper 
95% 
Lower 
95.0% 
Upper 
95.0% 
Intercept 
-
318.28571
43 
272.93716
1 
-
1.1661501
61 
0.308342
689 
-
1076.0807
59 
439.509
33 
-
1076.080
76 
439.5093
305 
X Variable 1 
18508.571
43 
450.74088
67 
41.062552
73 
2.10209E
-06 
17257.114
1 
19760.0
29 
17257.11
41 
19760.02
876 
         
         
         
         
4.1 Slope (b)  18508.57142857       
 
4.2 Y-intercept (a)  -318.28571429       
4.3 Linearity 
 
Fcalc   = 1686 
     
  
Fcalc large , therefore signifigant linearity 
    
 
         
5. REGRESSION UNCERTAINTIES        
         5.1 Random Uncertainty (Sy/x) 377.11688222 
      5.2 Slope Uncertainty (Sb) 450.74088670 
      5.3 Y-intercept Uncertainty (Sa) 272.93716104 
      
         
         
         
6. LIMIT OF DETECTION        
         YLOD=YB+3SB=bXLOD+a 
       Assume YB=a 
        Thus, XLOD=3Sb/b,ng/ℓ 
       0.073 ng/ℓ 
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6. LIMIT OF QUANTITATION        
         YLOQ=YB+10SB=bXLOQ+a 
       Assume YB=a 
        Thus, XLOQ=10Sb/b,ng/ℓ 
       0.244 ng/ℓ 
       
         
         
         
         
         
         
7. ACCURACY         
A spiked quality sample, concentration of  
 
0.5 mg/L 
   
         DETERMINATION CONCENTRATION PEAK HEIGHT 
      #1 0.5 8640.0 
      #2 0.5 9270.0 
      #3 0.6 10300.0 
      #4 0.5 8710.0 
      #5 0.5 9300.0 
      #6 0.4 7160.0 
      #7 0.5 9270.0 
      #8 0.5 8630.0 
      Mean 0.5 8910.0 
      Std Deviation 0.047 894.204 
      
         7.1 RSD of concentration, ( sx100/mean), % 
      9.33 
        
         7.2 Mean Method Accuracy (% of true conc.), % 
      100.9 
        
         7.3 Method Bias (deviation from true value), % 
      0.9 
        
         
 
8. UNCERTAINTY         
         8.1 Uncertainty of Regression 
       
         y0=bx0+a 
        For x0= 0.5044 
       y0= 9016.975 
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ave.y = 8910.00000000 
       y0-ave.y = 106.9750 
       (y0-ave.y)(y0-
ave.y) 11443.65062 
       
         
xi xi-ave.x 
(xi-ave.x)*(xi-
ave.x) 
      0.0000 -0.500 0.25 
      0.2000 -0.300 0.09 
      0.4000 -0.100 0.01 
      0.6000 0.100 0.01 
      0.8000 0.300 0.09 
      1.0000 0.500 0.25 
            
      
 
Sum = 0.7 
      
 
Sum2= 0.49 
      
         
Sx0= 
Sy/x/b{1/m+1/n+(y0-ave.y)
2/b2sum(xi-
ave.x)2}1/2 
  
m = determinations 
= 1 
  
     
n = calibration 
points =6 
  
 
Sx0= 0.022008435 
      
         8.2 Uncertainty of Repeatability 
       Std 
Dev.y/ave.y= 0.100359546 
       
         8.3 Uncertainty of Purity 
       Purity=100%+-
0.5% 
        Assume rectangular distrobution 
       U(P)=0.5/31/2= 0.29 
       
         8.4 Uncertainty of Volume 
       
         8.4.1 10mℓ  volumetric flask, S.N 
0134 
       10mℓ +-0.04mℓ , 20DC 
       Assume rectangular distrobution 
       U(V1)=0.04/3
1/2
= 0.023094011 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00021 
      Assume rectangular distrobution 
       U(V2)= Volume (Volume*temp. var.*coefficient of volume 
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variation= expansion)/31/2 
 
0.004849742 
       Volumetric Flask Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VA)/VA= 0.002359774 mℓ  
     
         8.4.2 100ul syringe 
       100ul+1ul, 
20DC 
        Assume rectangular distrobution 
       U(V1)=1/3
1/2= 0.577350269 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distrobution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
0.34410076 
       100ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VB)/VB= 0.006721151 ul 
     
         8.4.3 500ul syringe 
       500ul+5ul, 
20DC 
        Assume rectangular distrobution 
       U(V1)=5/3
1/2= 2.886751346 
       Lab 
temperature= 20DC+- 4 
      Coefficient of volume expansion= 0.00149 
      Assume rectangular distrobution 
       
U(V2)= 
Volume 
variation= 
(Volume*temp. var.*coefficient of volume 
expansion)/31/2 
    
 
1.720503802 
       500ul Syringe Uncertainty= {U(V1)
2+U(V2)
2}1/2 
      
 
U(VC)/VC= 0.003360575 ul 
     
         8.5 Uncertainty of Balance 
       
         
         
 
U(VD)/VD= 0.002 g 
     
         8.6 Total Uncertainty, at x0= 0.5 
      
U(t)/x0= 
{(Sx0/x0)
2+(SR/S)2+(U(P)/P)2+(U(VA)/VA)
2+(U(VB)/VB)
2+(U(VC)/VC)
2+(U(VD)
/VD)2}1/2 
    U(t)= 0.053789473 ng/ℓ 
      
         95% CL of x0: x0+/-
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{t4;0.05*U(t)} 
 
x0+/-{2.78*U(t)} 
       
 
0.5 ng/ℓ      +/- 0.1 ng/ℓ 
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Table 19: The table of calibration standards vs Area counts 
              
    17 a ethinylestradiol 17 a estradiol 17 b estradiol estrone 
Area 
S0 0.00 0.00 33.10 36.00 
S1 979.00 1640.00 1290.00 3240.00 
S2 2060.00 3220.00 3260.00 6640.00 
S3 3320.00 5180.00 4360.00 11000.00 
S4 4100.00 7190.00 5770.00 14200.00 
S5 5210.00 8400.00 7410.00 18500.00 
Concentration (ng/ℓ) 
S0 0.00 0.00 0.00 0.00 
S1 0.20 0.20 0.20 0.20 
S2 0.40 0.40 0.40 0.40 
S3 0.60 0.60 0.60 0.60 
S4 0.80 0.80 0.80 0.80 
S5 1.00 1.00 1.00 1.00 
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Table 20: The table of precision and accuracy of quality control standards 
              
              
  
17 a ethinylestradiol 17 a estradiol 17 b estradiol estrone 
Expected Conc. (ng/ℓ)   0.20 0.50 1.00 0.20 0.50 1.00 0.20 0.50 1.00 0.20 0.50 1.00 
Observed Std Conc. (ng/ℓ) 
 #1 0.199 0.522 0.990 0.30 0.47 0.96 0.20 0.50 0.89 0.26 0.46 0.88 
 #2 0.25 0.53 0.91 0.25 0.47 0.88 0.29 0.43 0.86 0.22 0.46 0.89 
 #3 0.18 0.41 0.87 0.31 0.47 0.89 0.25 0.52 0.91 0.09 0.46 0.90 
 #4 0.21 0.40 0.93 0.25 0.50 0.90 0.19 0.37 0.94 0.21 0.46 0.90 
 #5 0.25 0.46 0.93 0.22 0.47 0.87 0.20 0.47 0.88 0.23 0.46 0.95 
 #6 0.21 0.46 0.83 0.25 0.44 0.91 0.18 0.50 0.91 0.13 0.48 0.94 
 #7 0.21 0.49 0.94 0.35 0.47 0.90 0.15 0.43 0.83 0.17 0.50 0.96 
 #8 0.12 0.42 0.81 0.24 0.46 0.84 0.17   0.83 0.21 0.46 0.93 
  Average 0.20 0.46 0.90 0.27 0.47 0.89 0.20 0.46 0.88 0.19 0.47 0.92 
 
Std. Dev. 0.04 0.05 0.06 0.04 0.02 0.03 0.04 0.05 0.04 0.06 0.01 0.03 
 
%RSD 20.3 10.7 6.7 15.4 3.5 3.8 21.8 11.1 4.5 30.2 3.0 3.1 
 
% Accuracy 102.4 92.3 90.1 135.3 93.8 89.4 101.8 92.1 88.0 94.5 93.6 91.8 
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Table 21: Determination of robustness of quality control sample over a period of three days 
               17 a ethinylestradiol 17 a estradiol 17 b estradiol estrone 
Day 1 2 3 1 2 3 1 2 3 1 2 3 
 #1 0.43 0.52 0.47 0.46 0.47 0.38 0.48 0.50 0.63 0.49 0.46 0.41 
 #2 0.50 0.53 0.50 0.45 0.47 0.61 0.51 0.43 0.69 0.52 0.46 0.43 
 #3 0.57 0.41 0.39 0.54 0.47 0.23 0.59 0.52 0.55 0.58 0.46 0.50 
 #4 0.52 0.40 0.38 0.46 0.50 0.42 0.46 0.37 0.59 0.49 0.46 0.44 
 #5 0.47 0.46 0.41 0.49 0.47 0.53 0.53 0.47 0.58 0.53 0.46 0.47 
 #6 0.44 0.46 0.49 0.40 0.44 0.34 0.44 0.50 0.57 0.41 0.48 0.49 
 #7 0.49 0.49 0.29 0.51 0.47 0.35 0.49 0.43 0.50 0.52 0.50 0.47 
 #8 0.41 0.42 0.41 0.45 0.46 0.22 0.41   0.34 0.49 0.46 0.46 
Average 0.48 0.46 0.42 0.47 0.47 0.38 0.49 0.46 0.56 0.50 0.47 0.46 
Nominal  0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 
n 8 8 8 8 8 8 8 7 8 8 8 8 
Std. Dev. 0.0513 0.049 0.067 0.045 0.016 0.135 0.056 0.051 0.104 0.047 0.014 0.030 
s/√n 0.0181 0.017 0.024 0.016 0.006 0.048 0.020 0.019 0.037 0.017 0.005 0.011 
tcalc -1.22 -2.22 -3.51 -1.96 -5.34 -2.42 -0.62 -2.05 1.55 0.26 -6.48 -3.92 
tcrit 2.36 2.36 2.36 2.36 2.36 2.36 2.36 2.45 2.36 2.36 2.36 2.36 
Significant difference NO NO NO NO NO NO NO NO NO NO NO NO 
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Table 22: Summary of basic figures of merit 
      
        
COMPOUND Range, (ng/ℓ) F Factor 
Limit Of 
Detection, 
(ng/ℓ) 
Limit Of 
Quantitation, 
(ng/ℓ) 
17 a ethinylestradiol 0-1.00 1672 0.07 0.24 
17 a estradiol 0-1.00 1140 0.09 0.30 
17 b estradiol 0-1.00 986 0.10 0.32 
estrone 0-1.00 1686 0.07 0.24 
 
 
 
 
 
Table 23: Summary of basic method performance parameters 
         
         
COMPOUND Precision, (%) Accuracy, (%) Bias, (%) 
17 a ethinylestradiol 10.7 95.6 -4.4 
17 a Estradiol 9.6 93.8 -6.2 
17 b Estradiol 11.4 97.6 -2.4 
Estrone 9.3 100.9 0.9 
         
   
 
Table 24: Summary of measurement uncertainty for each analyte 
       
COMPOUND 
Uncertainty 
Concentration (ng/ℓ) Uncertainty (ng/ℓ), +/- 
17 a ethinylestradiol 0.48 0.14 
17 a estradiol 0.47 0.14 
17 b estradiol 0.49 0.15 
estrone 0.50 0.15 
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Annexure 2: Optimum conditions of measured parameters 
 
Table 25: Multiple Reaction Monitoring ions for hormones (Optimised 
conditions) 
Analyte Precursor ion Product ion Units 
Estrone 269.087 144.900 Da 
  183.100 Da 
Ethinylestradiol 295.064 144.100 Da 
  183.100 Da 
Estradiol 271.063 144.800 Da 
  182.800 Da 
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Annexure 3:Infusion and tuning conditions of the spectrometer 
 
 
 
Figure 12: EE2, initial Q1 
 
 
 
Figure 13: EE2, Final Q1 
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Figure 14: EE2, Final Product ion. 
 
 
 
Figure 15: E2, Initial Q1 
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Figure 16: E2, Final Q1 
 
 
 
Figure 16: E2, Final product ion 
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Figure 17: E1, Initial Q1 
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Figure 18: E1, Final Q1 
 
 
 
 
 
Figure 19: E1, Final Product ion 
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Figure 20: Infused mixture of hormones (10ng/mℓ) 
 
 
 
 
 
 
Figure 21: MRM EPI for 15 ng/mℓ 
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Annexure 4: Chromatograms of hormones 
 
 
 
 
Figure 22: Quantitation ion of estrone (269.087/144.900 Da) 
 
 
 
 
Figure 23: Quantitation ion 17 α estradiol (271.063/144.800 Da) 
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Figure 24: Quantitation ion 17 α ethinylestradiol (295.064/144.900 Da) 
 
 
 
Figure 25: Quantitation ion 17 β estradiol (271.063/144.801 Da) 
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Figure 26: Parent and daughter ions of estrogens  
 
Top: Green – parent ion, E2 (271.063/144.8), Bottom:  Gray – product ion, E2 
(271.063/182.8), Top: Blue – parent ion, EE2 (295.064/144.9), Bottom: Red – 
product ion, EE2 (295.064/183.1), Top: Powder blue – parent ion, E1 
(269.087/144.9), and Bottom: Pink – product ion, E1 (2693087/183.1). 
 
